Hereditary neurological disease
MONDO:0100545A heterogeneous group of genetic conditions with Mendelian (autosomal dominant, recessive, or X-linked) or chromosomal etiology characterized by abnormalities in the brain, spinal cord, nerves, or muscles.
Also known as: neurogenetic disease
5772 clinical trials for this condition and its sub-types, 6 tagged with Hereditary neurological disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hereditary neurological disease
-
Parkinson disease 1,165 trials · 1,292 incl. sub-types
6 sub-types
- Late-onset Parkinson disease 3 trials · 143 incl. sub-types Sub-types →
- Young-onset Parkinson disease 9 trials · 11 incl. sub-types Sub-types →
- Parkinson disease 16 0 trials
- Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development 0 trials
- Parkinson disease, mitochondrial 0 trials
- Parkinsonian-pyramidal syndrome 0 trials Sub-types →
-
Anxiety 1,030 trials
-
Hereditary neuromuscular disease 3 trials · 932 incl. sub-types
22 sub-types
- Hereditary peripheral neuropathy 6 trials · 478 incl. sub-types Sub-types →
- Muscular dystrophy 74 trials · 288 incl. sub-types Sub-types →
- Hereditary motor neuron disease 1 trial · 169 incl. sub-types Sub-types →
- Hereditary spastic paraplegia 27 trials · 33 incl. sub-types Sub-types →
- Benign paroxysmal positional vertigo 18 trials
- Meniere disease 16 trials Sub-types →
- RYR1-related myopathy 5 trials · 6 incl. sub-types Sub-types →
- Congenital myasthenic syndrome 5 trials Sub-types →
- Malignant hyperthermia of anesthesia 5 trials
- SCN4A-related channelopathy 1 trial · 2 incl. sub-types Sub-types →
- Early-onset myopathy with fatal cardiomyopathy 1 trial
- Andersen-Tawil syndrome 0 trials
- CNGB3-related retinopathy 0 trials Sub-types →
- KY-related neuromyopathy 0 trials Sub-types →
- Morimoto-Ryu-Malicdan neuromuscular syndrome 0 trials
- X-linked recessive mitochondrial myopathy 0 trials
- Myofibrillar myopathy 1 0 trials
- Myotonia congenita, autosomal dominant 0 trials
- Myotonia congenita, autosomal recessive 0 trials
- Neuromuscular disorder, congenital, with dysmorphic facies 0 trials
- Periodic paralysis with later-onset distal motor neuropathy 0 trials
- Vertigo, benign recurrent, 1 0 trials
-
Inherited neurodegenerative disorder 10 trials · 807 incl. sub-types
82 sub-types
- Frontotemporal dementia 132 trials · 178 incl. sub-types Sub-types →
- Hereditary motor neuron disease 1 trial · 169 incl. sub-types Sub-types →
- Hereditary cerebellar ataxia 0 trials · 116 incl. sub-types Sub-types →
- Huntington disease and related disorders 0 trials · 91 incl. sub-types Sub-types →
- Progressive supranuclear palsy 73 trials · 77 incl. sub-types Sub-types →
- Leukodystrophy 6 trials · 72 incl. sub-types Sub-types →
- Familial Alzheimer disease 13 trials · 55 incl. sub-types Sub-types →
- Hereditary spastic paraplegia 27 trials · 33 incl. sub-types Sub-types →
- Hereditary optic atrophy 6 trials · 23 incl. sub-types Sub-types →
- Neuronal ceroid lipofuscinosis 6 trials · 23 incl. sub-types Sub-types →
- GM2 gangliosidosis 14 trials · 19 incl. sub-types Sub-types →
- Kennedy disease 19 trials
- Corticobasal syndrome 19 trials
- Frontotemporal dementia with motor neuron disease 13 trials · 19 incl. sub-types Sub-types →
- Posterior cortical atrophy 11 trials
- Chediak-Higashi syndrome 9 trials
- Neurodegeneration with brain iron accumulation 1 trial · 8 incl. sub-types Sub-types →
- APP-related brain and vascular amyloidosis 0 trials · 5 incl. sub-types Sub-types →
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 0 trials · 5 incl. sub-types Sub-types →
- Inherited Creutzfeldt-Jakob disease 5 trials
- TUBB4A-related neurologic disorder 4 trials Sub-types →
- Fatal familial insomnia 4 trials
- Mitochondrial DNA depletion syndrome 4a 3 trials
- Alzheimer disease 17 1 trial
- Alzheimer disease 18 1 trial
- Ataxia-telangiectasia-like disorder 1 trial Sub-types →
- Developmental and epileptic encephalopathy, 35 1 trial
- Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures 1 trial
- Neurodegenerative syndrome due to cerebral folate transport deficiency 1 trial
- Neuronal intranuclear inclusion disease 1 trial
- Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome 1 trial
- DCTN1-related neurodegeneration 0 trials Sub-types →
- Huntington disease-like 1 0 trials
- Huntington disease-like 2 0 trials
- ITM2B amyloidosis 0 trials Sub-types →
- PEHO syndrome 0 trials
- PRKAR1B-related neurodegenerative dementia with intermediate filaments 0 trials
- X-linked neurodegenerative syndrome, Bertini type 0 trials
- X-linked neurodegenerative syndrome, Hamel type 0 trials
- Agenesis of the corpus callosum with peripheral neuropathy 0 trials
- Amyotrophic lateral sclerosis-parkinsonism-dementia complex 0 trials
- Angioid streaks of choroid 0 trials
- Attenuated Chédiak-Higashi syndrome 0 trials
- Autosomal recessive cerebral atrophy 0 trials
- Boylan dew greco syndrome 0 trials
- Cerebellar ataxia-hypogonadism syndrome 0 trials Sub-types →
- Cerebral sclerosis similar to Pelizaeus-Merzbacher disease 0 trials
- Combined oxidative phosphorylation deficiency 29 0 trials
- Deafness dystonia syndrome 0 trials
- Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome 0 trials
- Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities 0 trials
- Early-childhood-onset neurodegeneration with retinitis pigmentosa, sensorineural hearing loss, and demyelinating peripheral neuropathy 0 trials
- Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome 0 trials
- Encephalopathy due to beta-mercaptolactate-cysteine disulfiduria 0 trials
- Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 0 trials Sub-types →
- Facial onset sensory and motor neuronopathy 0 trials
- Fatal post-viral neurodegenerative disorder 0 trials
- Ferro-cerebro-cutaneous syndrome 0 trials
- Hereditary sensory neuropathy-deafness-dementia syndrome 0 trials
- Hypotonia, infantile, with psychomotor retardation and characteristic facies 0 trials Sub-types →
- Infantile cerebellar-retinal degeneration 0 trials
- Infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome 0 trials
- Microphthalmia-brain atrophy syndrome 0 trials
- Myoclonic cerebellar dyssynergia 0 trials
- Neurodegeneration and seizures due to copper transport defect 0 trials
- Neurodegeneration with ataxia and late-onset optic atrophy 0 trials
- Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset 0 trials
- Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities 0 trials
- Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline 0 trials
- Neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline 0 trials
- Neurodegeneration, childhood-onset, with cerebellar atrophy 0 trials
- Neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities 0 trials
- Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction 0 trials
- Neurodegeneration, childhood-onset, with progressive microcephaly 0 trials
- Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia 0 trials
- Neurodegeneration, infantile-onset, biotin-responsive 0 trials
- Neurodegenerative disorder with cerebellar and caudate atrophy 0 trials
- Neurodegenerative disorder, X-linked, female-restricted, with parkinsonism and cognitive impairment 0 trials
- Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome 0 trials
- Radiation sensitivity/chromosome instability syndrome, autosomal dominant 0 trials
- Severe neurodegenerative syndrome with lipodystrophy 0 trials
- Striatonigral degeneration 0 trials Sub-types →
-
Inherited retinal dystrophy 41 trials · 510 incl. sub-types
105 sub-types
- Age-related macular degeneration 190 trials · 334 incl. sub-types Sub-types →
- Retinitis pigmentosa 84 trials · 89 incl. sub-types Sub-types →
- Hereditary macular dystrophy 3 trials · 70 incl. sub-types Sub-types →
- Cone-rod dystrophy 17 trials · 21 incl. sub-types Sub-types →
- Leber congenital amaurosis 10 trials · 12 incl. sub-types Sub-types →
- ABCA4-related retinopathy 7 trials · 11 incl. sub-types Sub-types →
- BEST1-related dominant retinopathy 1 trial · 7 incl. sub-types Sub-types →
- RHO-related retinopathy 0 trials · 7 incl. sub-types Sub-types →
- RPE65-related recessive retinopathy 5 trials · 7 incl. sub-types Sub-types →
- RPGR-related retinopathy 0 trials · 7 incl. sub-types Sub-types →
- Choroideremia 6 trials Sub-types →
- PRPF31-related retinopathy 1 trial · 4 incl. sub-types Sub-types →
- X-linked retinoschisis 4 trials
- Ornithine aminotransferase deficiency 4 trials
- ELOVL4-related maculopathy 0 trials · 3 incl. sub-types Sub-types →
- RLBP1-related retinopathy 2 trials · 3 incl. sub-types Sub-types →
- Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations 3 trials
- BEST1-related recessive retinopathy 0 trials · 2 incl. sub-types Sub-types →
- EYS-related retinopathy 1 trial · 2 incl. sub-types Sub-types →
- LCA5-related retinopathy 1 trial · 2 incl. sub-types Sub-types →
- PRPH2-related retinopathy 1 trial · 2 incl. sub-types Sub-types →
- Revesz syndrome 2 trials
- Late-onset retinal degeneration 2 trials
- AIPL1-related retinopathy 1 trial Sub-types →
- ATF6-related retinopathy 0 trials · 1 incl. sub-types Sub-types →
- CNGB1-related retinopathy 0 trials · 1 incl. sub-types Sub-types →
- FLVCR1-related retinopathy with or without ataxia 0 trials · 1 incl. sub-types Sub-types →
- GUCY2D retinopathy 0 trials · 1 incl. sub-types Sub-types →
- RDH5-related retinopathy 0 trials · 1 incl. sub-types Sub-types →
- Retinoschisis of fovea 1 trial
- ADAM9-related retinopathy 0 trials Sub-types →
- CACNA1F-related retinopathy 0 trials Sub-types →
- CACNA2D4-related retinopathy 0 trials Sub-types →
- CDHR1-related retinopathy 0 trials Sub-types →
- CERKL-related retinopathy 0 trials Sub-types →
- CNGA1-related retinopathy 0 trials Sub-types →
- CNGA3-related retinopathy 0 trials Sub-types →
- CRX-related retinopathy 0 trials Sub-types →
- GNAT2-related retinopathy 0 trials Sub-types →
- GPR179-related retinopathy 0 trials Sub-types →
- GRM6-related retinopathy 0 trials Sub-types →
- GUCA1A-related retinopathy 0 trials Sub-types →
- HGSNAT-related retinopathy 0 trials Sub-types →
- IDH3B-related retinopathy 0 trials Sub-types →
- IMPDH1-related retinopathy 0 trials Sub-types →
- IMPG1-related dominant retinopathy 0 trials Sub-types →
- IMPG1-related recessive retinopathy 0 trials Sub-types →
- IMPG2-related dominant retinopathy 0 trials Sub-types →
- IMPG2-related recessive retinopathy 0 trials Sub-types →
- KCNV2-related retinopathy 0 trials Sub-types →
- KIZ-related retinopathy 0 trials Sub-types →
- LRIT3-related retinopathy 0 trials Sub-types →
- MAK-related retinopathy 0 trials Sub-types →
- MERTK-related retinopathy 0 trials Sub-types →
- MRCS syndrome 0 trials
- NMNAT1-related retinopathy 0 trials Sub-types →
- NYX-related retinopathy 0 trials Sub-types →
- Oguchi disease 0 trials Sub-types →
- PCARE-related retinopathy 0 trials Sub-types →
- PDE6A-related retinopathy 0 trials Sub-types →
- PDE6C-related retinopathy 0 trials Sub-types →
- PDE6G-related retinopathy 0 trials Sub-types →
- PROM1-related retinopathy 0 trials Sub-types →
- PRPF8-related retinopathy 0 trials Sub-types →
- RAB28-related retinopathy 0 trials Sub-types →
- RD3-related retinopathy 0 trials Sub-types →
- RDH12-related dominant retinopathy 0 trials
- RDH12-related recessive retinopathy 0 trials Sub-types →
- REEP6-related retinopathy 0 trials Sub-types →
- RP1-related dominant retinopathy 0 trials
- RP1-related recessive retinopathy 0 trials
- RP2-related retinopathy 0 trials Sub-types →
- RPE65-related dominant retinopathy 0 trials Sub-types →
- SNRNP200-related dominant retinopathy 0 trials Sub-types →
- SPATA7-related retinopathy 0 trials Sub-types →
- Sorsby fundus dystrophy 0 trials Sub-types →
- TOPORS-related retinopathy 0 trials Sub-types →
- TRPM1-related retinopathy 0 trials Sub-types →
- TTLL5-related retinopathy 0 trials Sub-types →
- X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome 0 trials
- X-linked retinal dysplasia 0 trials
- Aceruloplasminemia 0 trials
- Amaurosis-hypertrichosis syndrome 0 trials
- Choroideremia-deafness-obesity syndrome 0 trials
- Dystrophies primarily involving the retinal pigment epithelium 0 trials
- Ectopia lentis-chorioretinal dystrophy-myopia syndrome 0 trials
- Familial benign flecked retina 0 trials
- Foveal hypoplasia-presenile cataract syndrome 0 trials
- Helicoid peripapillary chorioretinal degeneration 0 trials
- Infantile cerebellar-retinal degeneration 0 trials
- Macular degeneration, early-onset 0 trials
- Microcephaly and chorioretinopathy 1 0 trials
- Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability 0 trials
- Microcornea-myopic chorioretinal atrophy 0 trials
- Oligocone trichromacy 0 trials
- Pigmented paravenous retinochoroidal atrophy 0 trials
- Progressive bifocal chorioretinal atrophy 0 trials
- Progressive retinal dystrophy due to retinol transport defect 0 trials
- Retinal degeneration-nanophthalmos-glaucoma syndrome 0 trials
- Retinal dystrophies primarily involving Bruch's membrane 0 trials Sub-types →
- Retinal dystrophy in systemic or cerebroretinal lipidoses 0 trials
- Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies 0 trials
- Retinal dystrophy, X-linked, Gardner-Hardcastle type 0 trials
- Retinoschisis, autosomal dominant 0 trials
- Vitreoretinal dystrophy 0 trials
-
Mendelian neurodevelopmental disorder 0 trials · 207 incl. sub-types
275 sub-types
- Genetic developmental and epileptic encephalopathy 2 trials · 83 incl. sub-types Sub-types →
- Prader-Willi syndrome 31 trials Sub-types →
- Rett syndrome 31 trials
- Intellectual disability, autosomal dominant 0 trials · 23 incl. sub-types Sub-types →
- X-linked intellectual disability 1 trial · 15 incl. sub-types Sub-types →
- CACNA1A-related complex neurodevelopmental disorder 1 trial · 9 incl. sub-types Sub-types →
- Autosomal recessive primary microcephaly 0 trials · 8 incl. sub-types Sub-types →
- Smith-Magenis syndrome 5 trials
- Rubinstein-Taybi syndrome 3 trials Sub-types →
- Alternating hemiplegia of childhood 3 trials Sub-types →
- FOXG1 disorder 2 trials
- GRIN-related complex neurodevelopmental disorder 2 trials Sub-types →
- Neurodevelopmental disorder with involuntary movements 2 trials
- CAMK2D-related neurodevelopmental disorder and dilated cardiomyopathy 1 trial
- Dyneinopathy 0 trials · 1 incl. sub-types Sub-types →
- Intellectual disability, autosomal recessive 0 trials · 1 incl. sub-types Sub-types →
- Microcephalic osteodysplastic primordial dwarfism type I 1 trial
- Microcephalic osteodysplastic primordial dwarfism type II 1 trial
- Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction 1 trial
- Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA 1 trial
- Orofaciodigital syndrome I 1 trial
- AFG2B-related complex neurodevelopmental disorder with motor features and hearing loss 0 trials
- AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome 0 trials
- ARF3-related neurodevelopmental disorder 0 trials
- ATXN7L3-related developmental delay, hypotonia and facial dysmorphism 0 trials
- Alzahrani-Kuwahara syndrome 0 trials
- Amish lethal microcephaly 0 trials
- Au-Kline syndrome 0 trials
- Brunet-Wagner neurodevelopmental syndrome 0 trials
- CBX1-related neurodevelopmental disorder 0 trials
- CK syndrome 0 trials
- CNOT9-related developmental disorder with seizures 0 trials
- CTR9-related neurodevelopmental disorder 0 trials
- Chilton-Okur-Chung neurodevelopmental syndrome 0 trials
- DDX17-related neurodevelopmental disorder 0 trials
- DEAF1-associated neurodevelopmental disorder 0 trials Sub-types →
- DIP2C-related developmental disorder with speech delay 0 trials
- Delpire-McNeill syndrome 0 trials
- Dentici-Novelli neurodevelopmental syndrome 0 trials
- Dursun-Ozgul neurodevelopmental syndrome 0 trials
- Dworschak-Punetha neurodevelopmental syndrome 0 trials
- EPB41L3-related developmental disorder with delayed myelination and seizures 0 trials
- El Hayek-Chahrour neurodevelopmental disorder 0 trials
- FAT4-related neurodevelopmental disorder 0 trials
- FEZF2-related neurodevelopmental disorder 0 trials
- Ferguson-Bonni neurodevelopmental syndrome 0 trials
- GABRA4-related neurodevelopmental disorder with seizures 0 trials
- GABRD-related neurodevelopmental disorder with epilepsy 0 trials
- HDAC3-related neurodevelopmental disorder 0 trials
- HMGB1-related brachyphalangy, polydactyly and tibial aplasia syndrome 0 trials
- HNRNPC-related neurodevelopmental disorder 0 trials Sub-types →
- Hao-Fountain syndrome due to USP7 mutation 0 trials
- Harel-Tora neurodevelopmental syndrome 0 trials
- Harel-Yoon syndrome 0 trials
- Hiatt-Neu-Cooper neurodevelopmental syndrome 0 trials
- Houge-Janssens syndrome 3 0 trials
- Jeffries-Lakhani neurodevelopmental syndrome 0 trials
- KCND2-related neurodevelopmental disorder with or without seizures 0 trials
- KCNH1 associated disorder 0 trials Sub-types →
- KCNK3-related developmental delay with sleep apnea 0 trials
- KDM2B-related neurodevelopmental disorder 0 trials
- Karayol-Borroto-Haghshenas neurodevelopmental syndrome 0 trials
- Kariminejad neurodevelopmental syndrome 0 trials
- Li-Takada-Miyake syndrome 0 trials
- MYCBP2-related developmental delay with corpus callosum defects 0 trials
- MYH10-related neurodevelopmental disorder with congenital anomalies 0 trials
- Marbach-Schaaf neurodevelopmental syndrome 0 trials
- NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability 0 trials
- Nil-Deshwar neurodevelopmental syndrome 0 trials
- Okur-Chung neurodevelopmental syndrome 0 trials
- PAX5-related B lymphopenia and autism spectrum disorder 0 trials
- PIP5K1C-related neurodevelopmental disorder 0 trials
- PPFIA3-related neurodevelopmental disorder 0 trials
- PPP2R1A-related intellectual disability 0 trials
- PRPF19-related neurodevelopmental disorder 0 trials
- Pitt-Hopkins-like syndrome 2 0 trials
- Poirier-Bienvenu neurodevelopmental syndrome 0 trials
- Popov-Chang syndrome 0 trials
- RFX3-related neurodevelopmental disorder with autism and other behavioural abnormalities 0 trials
- RFX4-related neurodevelopmental disorder with autism and other behavioural abnormalities 0 trials
- RNU5B-1 related neurodevelopmental disorder with seizures and joint laxity 0 trials
- Ramond-Elliott neurodevelopmental syndrome 0 trials
- SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth 0 trials Sub-types →
- SOX11-related complex neurodevelopmental disorder with or without congenital anomalies 0 trials
- SYNCRIP-related neurodevelopmental disorder 0 trials
- Stankiewicz-Isidor syndrome 0 trials
- TRA2B-related neurodevelopmental disorder 0 trials
- WDR5-related neurodevelopmental disorder 0 trials
- Wieacker-Wolff syndrome 0 trials
- X-linked complex neurodevelopmental disorder 0 trials Sub-types →
- Aplasia cutis-enamel dysplasia syndrome 0 trials
- Autosomal dominant primary microcephaly 0 trials Sub-types →
- Cerebellar atrophy, visual impairment, and psychomotor retardation; 0 trials
- Cerebral palsy, spastic quadriplegic, 2 0 trials
- Cerebral palsy, spastic quadriplegic, 3 0 trials
- Complex cortical dysplasia with other brain malformations 5 0 trials
- Developmental delay and seizures with or without movement abnormalities 0 trials
- Developmental delay with autism spectrum disorder and gait instability 0 trials
- Developmental delay with variable intellectual impairment and behavioral abnormalities 0 trials
- Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities 0 trials
- Intellectual developmental disorder and retinitis pigmentosa; IDDRP 0 trials
- Intellectual developmental disorder with polymicrogyria and seizures 0 trials
- Intellectual disability, autosomal dominant 29 0 trials
- Microcephalic osteodysplastic primordial dwarfism, type 3 0 trials
- Microcephaly and chorioretinopathy 0 trials Sub-types →
- Microcephaly with lissencephaly and/or hydranencephaly 0 trials Sub-types →
- Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability 0 trials
- Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia 0 trials
- Neurocardiorenal malformation syndrome 0 trials
- Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity 0 trials
- Neurodevelopmental disorder plus optic atrophy 0 trials
- Neurodevelopmental disorder with absent language and variable seizures 0 trials
- Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with achalasia, polyneuropathy, and alacrima 0 trials
- Neurodevelopmental disorder with alopecia and brain abnormalities 0 trials
- Neurodevelopmental disorder with ataxia and brain abnormalities 0 trials
- Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly 0 trials
- Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter 0 trials
- Neurodevelopmental disorder with behavioral abnormalities and childhood-onset spastic paraplegia 0 trials
- Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia 0 trials
- Neurodevelopmental disorder with behavioral, ear, and skeletal abnormalities 0 trials
- Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies 0 trials
- Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities 0 trials
- Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies 0 trials
- Neurodevelopmental disorder with central and peripheral motor dysfunction 0 trials
- Neurodevelopmental disorder with central hypotonia and dysmorphic facies 0 trials Sub-types →
- Neurodevelopmental disorder with cerebellar atrophy and with or without seizures 0 trials
- Neurodevelopmental disorder with cerebellar hypoplasia and spasticity 0 trials
- Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism 0 trials
- Neurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1 0 trials
- Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities 0 trials
- Neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities 0 trials
- Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects 0 trials
- Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia 0 trials
- Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies 0 trials
- Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies 0 trials
- Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia 0 trials
- Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities 0 trials
- Neurodevelopmental disorder with dysmorphic facies and thin corpus callosum 0 trials
- Neurodevelopmental disorder with dysmorphic facies and variable seizures 0 trials
- Neurodevelopmental disorder with dysmorphic facies, absent speech and ambulation, and brain abnormalities 0 trials
- Neurodevelopmental disorder with dysmorphic facies, brain anomalies, and seizures 0 trials
- Neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia 0 trials
- Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities 0 trials
- Neurodevelopmental disorder with dystonia and seizures 0 trials
- Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with early-onset seizures, facial dysmorphism, and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with epilepsy and brain atrophy 0 trials
- Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum 0 trials
- Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination 0 trials
- Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy 0 trials
- Neurodevelopmental disorder with eye movement abnormalities and ataxia 0 trials
- Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-pelger-huet anomaly 0 trials
- Neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked 0 trials
- Neurodevelopmental disorder with growth impairment, quadriparesis, and poor or absent speech 0 trials
- Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities 0 trials
- Neurodevelopmental disorder with hearing loss and spasticity 0 trials
- Neurodevelopmental disorder with hyperkinetic movements and dyskinesia 0 trials
- Neurodevelopmental disorder with hyperkinetic movements, seizures, and structural brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements 0 trials
- Neurodevelopmental disorder with hypotonia and brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia and characteristic brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia and dysmorphic facies 0 trials
- Neurodevelopmental disorder with hypotonia and gross motor and speech delay 0 trials
- Neurodevelopmental disorder with hypotonia and seizures 0 trials
- Neurodevelopmental disorder with hypotonia and speech delay, with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, brain anomalies, distinctive facies, and absent language 0 trials
- Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, epilepsy, and absent speech 0 trials
- Neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, feeding difficulties, facial dysmorphism, and brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia, microcephaly, and seizures 0 trials
- Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation 0 trials
- Neurodevelopmental disorder with hypotonia, neuropathy, and deafness 0 trials
- Neurodevelopmental disorder with hypotonia, poor growth, dysmorphic facies, and agammaglobulinemia 0 trials
- Neurodevelopmental disorder with hypotonia, seizures, and absent language 0 trials
- Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia 0 trials
- Neurodevelopmental disorder with impaired language and ataxia and with or without seizures 0 trials
- Neurodevelopmental disorder with impaired language, behavioral abnormalities, and dysmorphic facies 0 trials
- Neurodevelopmental disorder with impaired speech and hyperkinetic movements 0 trials
- Neurodevelopmental disorder with infantile epileptic spasms 0 trials
- Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies 0 trials
- Neurodevelopmental disorder with intracranial hemorrhage, seizures, and spasticity 0 trials
- Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures 0 trials
- Neurodevelopmental disorder with language delay and seizures 0 trials
- Neurodevelopmental disorder with language delay and variable cognitive abnormalities 0 trials
- Neurodevelopmental disorder with language impairment and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder 0 trials
- Neurodevelopmental disorder with microcephaly and dysmorphic facies 0 trials
- Neurodevelopmental disorder with microcephaly and movement abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly and structural brain anomalies 0 trials
- Neurodevelopmental disorder with microcephaly, absent speech, and hypotonia 0 trials
- Neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies 0 trials
- Neurodevelopmental disorder with microcephaly, ataxia, and seizures 0 trials
- Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment 0 trials
- Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity 0 trials
- Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy 0 trials
- Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination 0 trials
- Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies 0 trials
- Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures 0 trials
- Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures 0 trials
- Neurodevelopmental disorder with microcephaly, seizures, and brain atrophy 0 trials
- Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy 0 trials
- Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis 0 trials
- Neurodevelopmental disorder with microcephaly, short stature, and speech delay 0 trials
- Neurodevelopmental disorder with midbrain and hindbrain malformations 0 trials
- Neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphism 0 trials
- Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities 0 trials
- Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with motor regression, progressive spastic paraplegia, and oromotor dysfunction 0 trials
- Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features 0 trials
- Neurodevelopmental disorder with neuromuscular and skeletal abnormalities 0 trials
- Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures 0 trials
- Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart 0 trials
- Neurodevelopmental disorder with or without autism or seizures 0 trials
- Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities 0 trials
- Neurodevelopmental disorder with or without early-onset generalized epilepsy 0 trials
- Neurodevelopmental disorder with or without seizures and gait abnormalities 0 trials
- Neurodevelopmental disorder with or without variable movement or behavioral abnormalities 0 trials
- Neurodevelopmental disorder with poor growth and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with poor growth and skeletal anomalies 0 trials
- Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies 0 trials
- Neurodevelopmental disorder with poor growth, seizures, and brain abnormalities 0 trials
- Neurodevelopmental disorder with poor language and loss of hand skills 0 trials
- Neurodevelopmental disorder with poor or absent speech, dysmorphic facies, and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 0 trials
- Neurodevelopmental disorder with progressive movement abnormalities 0 trials
- Neurodevelopmental disorder with progressive spasticity and brain abnormalities 0 trials
- Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities 0 trials
- Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures 0 trials
- Neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies 0 trials
- Neurodevelopmental disorder with seizures and brain atrophy 0 trials
- Neurodevelopmental disorder with seizures and gingival overgrowth 0 trials
- Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements 0 trials
- Neurodevelopmental disorder with seizures and speech and walking impairment 0 trials
- Neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities 0 trials
- Neurodevelopmental disorder with seizures, hypotonia, and variable spasticity 0 trials
- Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 0 trials
- Neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum 0 trials
- Neurodevelopmental disorder with severe motor impairment and absent language 0 trials
- Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy 0 trials
- Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties 0 trials
- Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures 0 trials
- Neurodevelopmental disorder with spastic quadriplegia, optic atrophy, seizures, and structural brain anomalies 0 trials
- Neurodevelopmental disorder with spasticity and poor growth 0 trials
- Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia 0 trials
- Neurodevelopmental disorder with spasticity, seizures, and brain abnormalities 0 trials
- Neurodevelopmental disorder with spasticity, thin corpus callosum, and decreased brain white matter 0 trials
- Neurodevelopmental disorder with speech delay and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with speech delay and variable ocular anomalies 0 trials
- Neurodevelopmental disorder with speech delay, movement abnormalities, and seizures 0 trials
- Neurodevelopmental disorder with speech impairment and dysmorphic facies 0 trials
- Neurodevelopmental disorder with speech impairment and with or without seizures 0 trials
- Neurodevelopmental disorder with speech or visual impairment and brain hypomyelination 0 trials
- Neurodevelopmental disorder with structural brain abnormalities and craniofacial abnormalities 0 trials
- Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies 0 trials
- Neurodevelopmental disorder with thin corpus callosum, hypotonia, and absent language 0 trials
- Neurodevelopmental disorder with variable familial hypercholanemia 0 trials
- Neurodevelopmental disorder with visual defects and brain anomalies 0 trials
- Neurodevelopmental disorder with white matter abnormalities and gait disturbance 0 trials
- Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures 0 trials
- Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus 0 trials
- Otofacial neurodevelopmental syndrome 0 trials
- Parenti-mignot neurodevelopmental syndrome 0 trials
- Squalene synthase deficiency 0 trials
-
Obsessive-compulsive disorder 196 trials
-
Hereditary ataxia 2 trials · 119 incl. sub-types
20 sub-types
- Hereditary cerebellar ataxia 0 trials · 116 incl. sub-types Sub-types →
- Spastic ataxia 1 trial · 2 incl. sub-types Sub-types →
- EAST syndrome 1 trial
- Hereditary episodic ataxia 0 trials · 1 incl. sub-types Sub-types →
- Hereditary spastic paraplegia 7 1 trial
- Richards-Rundle syndrome 0 trials
- Ataxia with fasciculations 0 trials
- Ataxia-hypogonadism-choroidal dystrophy syndrome 0 trials
- Ataxia-tapetoretinal degeneration syndrome 0 trials
- Autosomal dominant sensory ataxia 1 0 trials
- Autosomal recessive ataxia due to PEX16 deficiency 0 trials
- Autosomal recessive ataxia due to PEX2 deficiency 0 trials
- Cataract-ataxia-deafness syndrome 0 trials
- Ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome 0 trials
- Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome 0 trials
- Muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome 0 trials
- Myoclonus-cerebellar ataxia-deafness syndrome 0 trials
- Severe microbrachycephaly-intellectual disability-athetoid cerebral palsy syndrome 0 trials
- Spinocerebellar ataxia-dysmorphism syndrome 0 trials
- Tremor-ataxia-central hypomyelination syndrome 0 trials
-
Essential tremor 102 trials · 104 incl. sub-types
6 sub-types
- Tremor, hereditary essential, 1 2 trials
- Tremor, hereditary essential, 2 0 trials
- Tremor, hereditary essential, 3 0 trials
- Tremor, hereditary essential, 4 0 trials
- Tremor, hereditary essential, 5 0 trials
- Tremor, hereditary essential, 6 0 trials
-
Neurofibromatosis 19 trials · 94 incl. sub-types
5 sub-types
- Neurofibromatosis type 1 73 trials Sub-types →
- NF2-related schwannomatosis 21 trials
- Schwannomatosis 3 trials Sub-types →
- Neurofibromatosis-Noonan syndrome 2 trials Sub-types →
- Neurofibromatosis, type IV, of Riccardi 0 trials
-
Inherited orthostatic hypotension 0 trials · 71 incl. sub-types
3 sub-types
- Postural orthostatic tachycardia syndrome 71 trials
- Orthostatic hypotension 1 0 trials
- Orthostatic hypotension 2 0 trials
-
Nonsyndromic genetic hearing loss 4 trials · 67 incl. sub-types
6 sub-types
- Prelingual non-syndromic genetic hearing loss 5 trials · 37 incl. sub-types Sub-types →
- X-linked nonsyndromic hearing loss 0 trials · 32 incl. sub-types Sub-types →
- Hearing loss, autosomal recessive 1 trial · 17 incl. sub-types Sub-types →
- Postlingual non-syndromic genetic hearing loss 6 trials · 10 incl. sub-types Sub-types →
- Autosomal dominant nonsyndromic hearing loss 1 trial · 2 incl. sub-types Sub-types →
- Nonsyndromic deafness, Y-linked 0 trials Sub-types →
-
Inherited vitreoretinopathy 0 trials · 58 incl. sub-types
5 sub-types
- Vitreoretinal degeneration 0 trials · 45 incl. sub-types Sub-types →
- Congenital vitreoretinal dysplasia 0 trials · 9 incl. sub-types Sub-types →
- Vitreous detachment 5 trials
- NDP-related vitreoretinopathy 0 trials Sub-types →
- TSPAN12-related vitreoretinopathy 0 trials Sub-types →
-
Paraganglioma 53 trials · 57 incl. sub-types
12 sub-types
- Sympathetic paraganglioma 0 trials · 16 incl. sub-types Sub-types →
- Head and neck paraganglioma 1 trial Sub-types →
- Non-secreting paraganglioma 0 trials Sub-types →
- Parasympathetic paraganglioma 0 trials Sub-types →
- Pheochromocytoma/paraganglioma syndrome 1 0 trials
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 3 0 trials
- Pheochromocytoma/paraganglioma syndrome 4 0 trials
- Pheochromocytoma/paraganglioma syndrome 5 0 trials
- Pheochromocytoma/paraganglioma syndrome 6 0 trials
- Pheochromocytoma/paraganglioma syndrome 7 0 trials
- Sporadic pheochromocytoma/secreting paraganglioma 0 trials Sub-types →
-
Retinal detachment 28 trials · 52 incl. sub-types
2 sub-types
- Rhegmatogenous retinal detachment 23 trials Sub-types →
- Retinal perforation 18 trials
-
Tuberous sclerosis 41 trials · 44 incl. sub-types
2 sub-types
- Tuberous sclerosis 1 33 trials
- Tuberous sclerosis 2 2 trials
-
Endogenous depression 42 trials
-
Specific phobia 22 trials · 42 incl. sub-types
3 sub-types
- Nosophobia 2 trials · 16 incl. sub-types Sub-types →
- Animal phobia 5 trials
- Flying phobia 1 trial
-
Combined pituitary hormone deficiencies, genetic form 1 trial · 42 incl. sub-types
9 sub-types
- Isolated congenital growth hormone deficiency 38 trials Sub-types →
- Panhypopituitarism 2 trials Sub-types →
- Congenital isolated adrenocorticotropic hormone deficiency 1 trial
- Pituitary hormone deficiency, combined, 1 1 trial
- Septooptic dysplasia 1 trial Sub-types →
- Non-acquired combined pituitary hormone deficiency with spine abnormalities 0 trials
- Pituitary hormone deficiency, combined or isolated, 8 0 trials
- Pituitary hormone deficiency, combined, 6 0 trials
- Short stature-pituitary and cerebellar defects-small sella turcica syndrome 0 trials
-
Tourette syndrome 41 trials
-
Familial partial epilepsy 0 trials · 39 incl. sub-types
7 sub-types
- Temporal lobe epilepsy 31 trials Sub-types →
- Mesial temporal lobe epilepsy with hippocampal sclerosis 10 trials
- Self-limited epilepsy with centrotemporal spikes 3 trials Sub-types →
- Generalized epilepsy-paroxysmal dyskinesia syndrome 1 trial
- Autosomal dominant epilepsy with auditory features 0 trials
- Familial focal epilepsy with variable foci 0 trials Sub-types →
- Familial sleep-related hypermotor epilepsy 0 trials Sub-types →
-
Cerebral lipidosis with dementia 0 trials · 38 incl. sub-types
8 sub-types
- Sandhoff disease 13 trials Sub-types →
- Tay-Sachs disease 13 trials Sub-types →
- Gaucher disease type I 12 trials
- Cerebrotendinous xanthomatosis 6 trials
- Juvenile neuronal ceroid lipofuscinosis 6 trials Sub-types →
- Adult Krabbe disease 0 trials
- Adult neuronal ceroid lipofuscinosis 0 trials Sub-types →
- Infantile neuronal ceroid lipofuscinosis 0 trials Sub-types →
-
Inherited dystonia 0 trials · 36 incl. sub-types
24 sub-types
- Combined dystonia 1 trial · 12 incl. sub-types Sub-types →
- Isolated dystonia 4 trials · 11 incl. sub-types Sub-types →
- Lymphatic malformation 5 8 trials
- Dystonia, focal, task-specific 4 trials
- Dopa-responsive dystonia due to sepiapterin reductase deficiency 1 trial
- Dystonia 28, childhood-onset 1 trial
- Torsion dystonia 7 1 trial
- Woodhouse-Sakati syndrome 0 trials
- Ataxia - oculomotor apraxia type 4 0 trials
- Autosomal dominant dopa-responsive dystonia 0 trials Sub-types →
- Developmental malformations-deafness-dystonia syndrome 0 trials
- Dystonia 22, adult-onset 0 trials
- Dystonia 22, juvenile-onset 0 trials
- Dystonia 30 0 trials
- Dystonia 31 0 trials
- Dystonia 32 0 trials
- Dystonia 33 0 trials
- Dystonia 34, myoclonic 0 trials
- Dystonia 35, childhood-onset 0 trials
- Dystonia 37, early-onset, with striatal lesions 0 trials
- Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities 0 trials
- Familial idiopathic torsion dystonia 0 trials
- Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome 0 trials
- Striatonigral degeneration, childhood-onset 0 trials
-
Normal pressure hydrocephalus 35 trials
-
Mismatch repair cancer syndrome 1 34 trials
-
Hereditary generalized epilepsy 0 trials · 33 incl. sub-types
2 sub-types
- Idiopathic generalized epilepsy 11 trials · 29 incl. sub-types Sub-types →
- Generalized epilepsy with febrile seizures plus 0 trials · 4 incl. sub-types Sub-types →
-
X-linked deafness 0 trials · 32 incl. sub-types
2 sub-types
- X-linked nonsyndromic hearing loss 0 trials · 32 incl. sub-types Sub-types →
- X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome 0 trials
-
Familial isolated pituitary adenoma 1 trial · 31 incl. sub-types
6 sub-types
- Cushing disease due to pituitary adenoma 23 trials
- Prolactin-producing pituitary gland adenoma 11 trials
- Growth hormone secreting pituitary adenoma 1 1 trial
- Pituitary adenoma 3, multiple types 0 trials
- Pituitary adenoma 5, multiple types 0 trials
- Pituitary adenoma, growth hormone-secreting, 2 0 trials
-
Von Hippel-Lindau disease 27 trials
-
Specific language impairment 26 trials
5 sub-types
- Specific language impairment 1 0 trials
- Specific language impairment 2 0 trials
- Specific language impairment 3 0 trials
- Specific language impairment 4 0 trials
- Specific language impairment 5 0 trials
-
Stutter disorder 22 trials
4 sub-types
- Stuttering, familial persistent, 1 0 trials
- Stuttering, familial persistent, 2 0 trials
- Stuttering, familial persistent, 3 0 trials
- Stuttering, familial persistent, 4 0 trials
-
Moyamoya disease 20 trials
8 sub-types
- Moyamoya disease 2 0 trials
- Moyamoya disease 5 0 trials
- Moyamoya disease 8 0 trials
- Moyamoya disease with early-onset achalasia 0 trials
- Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome 0 trials
- Moyamoya disease 1 0 trials
- Moyamoya disease 3 0 trials
- Moyamoya disease 7 0 trials
-
Angelman syndrome 19 trials
-
Cerebral amyloid angiopathy 16 trials · 17 incl. sub-types
4 sub-types
- ACys amyloidosis 1 trial
- Cerebral amyloid angiopathy, APP-related 0 trials · 1 incl. sub-types Sub-types →
- ABri amyloidosis 0 trials
- ADan amyloidosis 0 trials
-
Li-Fraumeni syndrome 16 trials
-
Childhood apraxia of speech 16 trials
-
Intracranial berry aneurysm 12 trials
12 sub-types
- Aneurysm, intracranial berry type 1 0 trials
- Aneurysm, intracranial berry, 10 0 trials
- Aneurysm, intracranial berry, 11 0 trials
- Aneurysm, intracranial berry, 12 0 trials
- Aneurysm, intracranial berry, 2 0 trials
- Aneurysm, intracranial berry, 3 0 trials
- Aneurysm, intracranial berry, 4 0 trials
- Aneurysm, intracranial berry, 5 0 trials
- Aneurysm, intracranial berry, 6 0 trials
- Aneurysm, intracranial berry, 7 0 trials
- Aneurysm, intracranial berry, 8 0 trials
- Aneurysm, intracranial berry, 9 0 trials
-
Progressive myoclonus epilepsy 5 trials · 12 incl. sub-types
15 sub-types
- MERRF syndrome 5 trials
- Lafora disease 1 trial Sub-types →
- Unverricht-Lundborg syndrome 1 trial
- Neuronal ceroid lipofuscinosis 8 northern epilepsy variant 1 trial
- Action myoclonus-renal failure syndrome 0 trials
- Early-onset Lafora body disease 0 trials
- Epilepsy, progressive myoclonic, 11 0 trials
- Epilepsy, progressive myoclonic, 12 0 trials
- Epilepsy, progressive myoclonic, 1B 0 trials
- Familial encephalopathy with neuroserpin inclusion bodies 0 trials
- Progressive myoclonic epilepsy type 3 0 trials
- Progressive myoclonic epilepsy type 6 0 trials
- Progressive myoclonic epilepsy type 7 0 trials
- Progressive myoclonic epilepsy type 8 0 trials
- Progressive myoclonic epilepsy type 9 0 trials
-
DiGeorge syndrome 11 trials
-
Major affective disorder 6 11 trials
-
Auditory neuropathy 7 trials · 11 incl. sub-types
5 sub-types
-
Spastic quadriplegic cerebral palsy 10 trials
-
Chiari malformation type I 9 trials
-
Neurohypophyseal diabetes insipidus 9 trials
-
Sturge-Weber syndrome 8 trials
-
Progressive external ophthalmoplegia 4 trials · 8 incl. sub-types
3 sub-types
- Kearns-Sayre syndrome 5 trials
- Progressive external ophthalmoplegia with mitochondrial DNA deletions 0 trials · 2 incl. sub-types Sub-types →
- Autosomal recessive progressive external ophthalmoplegia 0 trials Sub-types →
-
Qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan 0 trials · 8 incl. sub-types
9 sub-types
- Qualitative or quantitative defects of FKRP 0 trials · 8 incl. sub-types Sub-types →
- Myopathy caused by variation in FKTN 1 trial · 2 incl. sub-types Sub-types →
- Myopathy caused by variation in CRPPA 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in GMPPB 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in POMT1 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in POMT2 0 trials · 1 incl. sub-types Sub-types →
- Qualitative or quantitative defects of protein O-mannosyltransferase 1 0 trials · 1 incl. sub-types Sub-types →
- Qualitative or quantitative defects of protein O-mannosyltransferase 2 0 trials · 1 incl. sub-types Sub-types →
- Limb-girdle muscular dystrophy due to POMK deficiency 0 trials
-
Red-green color blindness 7 trials
-
Duane retraction syndrome 6 trials
4 sub-types
- Duane retraction syndrome 2 0 trials
- Duane retraction syndrome 3 with or without deafness 0 trials
- Duane retraction syndrome with congenital deafness 0 trials
- Duane syndrome type 1 0 trials
-
Arthrogryposis 4 trials · 6 incl. sub-types
5 sub-types
- Freeman-Sheldon syndrome 1 trial Sub-types →
- Congenital contractural arachnodactyly 1 trial
- Boylan dew greco syndrome 0 trials
- Distal arthrogryposis Moore weaver type 0 trials
- Massa casaer ceulemans syndrome 0 trials
-
Undetermined early-onset epileptic encephalopathy 1 trial · 6 incl. sub-types
16 sub-types
- Developmental and epileptic encephalopathy, 13 3 trials
- Developmental and epileptic encephalopathy, 25 1 trial
- Developmental and epileptic encephalopathy, 42 1 trial
- Developmental and epileptic encephalopathy, 21 0 trials
- Developmental and epileptic encephalopathy, 24 0 trials
- Developmental and epileptic encephalopathy, 26 0 trials
- Developmental and epileptic encephalopathy, 28 0 trials
- Developmental and epileptic encephalopathy, 29 0 trials
- Developmental and epileptic encephalopathy, 31A 0 trials
- Developmental and epileptic encephalopathy, 32 0 trials
- Developmental and epileptic encephalopathy, 33 0 trials
- Developmental and epileptic encephalopathy, 41 0 trials
- Developmental and epileptic encephalopathy, 44 0 trials
- Developmental and epileptic encephalopathy, 45 0 trials
- Developmental and epileptic encephalopathy, 46 0 trials
- Developmental and epileptic encephalopathy, 47 0 trials
-
Inborn aminoacylase deficiency 0 trials · 6 incl. sub-types
2 sub-types
- Canavan disease 6 trials Sub-types →
- Aminoacylase 1 deficiency 0 trials
-
Narcolepsy 1 5 trials
-
Nevoid basal cell carcinoma syndrome 5 trials
2 sub-types
- Basal cell nevus syndrome 1 0 trials
- Basal cell nevus syndrome 2 0 trials
-
GLUT1 deficiency syndrome 4 trials · 5 incl. sub-types
2 sub-types
-
Congenital nystagmus 4 trials · 5 incl. sub-types
10 sub-types
- Spinocerebellar ataxia 27A 1 trial
- Nystagmus 1, congenital, X-linked 0 trials
- Nystagmus 2, congenital, autosomal dominant 0 trials
- Nystagmus 3, congenital, autosomal dominant 0 trials
- Nystagmus 5, congenital, X-linked 0 trials
- Nystagmus 6, congenital, X-linked 0 trials
- Nystagmus 7, congenital, autosomal dominant 0 trials
- Nystagmus, congenital, autosomal recessive 0 trials
- Nystagmus, hereditary vertical 0 trials
- Nystagmus, myoclonic 0 trials
-
Congenital stationary night blindness 2 trials · 5 incl. sub-types
14 sub-types
- Congenital stationary night blindness autosomal dominant 1 3 trials
- Congenital stationary night blindness autosomal dominant 2 1 trial
- Oguchi disease 0 trials Sub-types →
- X-linked congenital stationary night blindness 0 trials Sub-types →
- Cone-rod synaptic disorder, congenital nonprogressive 0 trials
- Congenital stationary night blindness 1B 0 trials
- Congenital stationary night blindness 1C 0 trials
- Congenital stationary night blindness 1D 0 trials
- Congenital stationary night blindness 1E 0 trials
- Congenital stationary night blindness 1F 0 trials
- Congenital stationary night blindness 1G 0 trials
- Congenital stationary night blindness 1H 0 trials
- Congenital stationary night blindness autosomal dominant 3 0 trials
- Night blindness, congenital stationary, type1i 0 trials
-
Qualitative or quantitative defects of beta-sarcoglycan 0 trials · 5 incl. sub-types
1 sub-type
-
Corpus callosum, agenesis of 4 trials
2 sub-types
- Kozlowski Ouvrier syndrome 0 trials
- Calloso-genital dysplasia 0 trials
-
Velocardiofacial syndrome 4 trials
-
TTN-related myopathy 2 trials · 4 incl. sub-types
2 sub-types
- Autosomal recessive titinopathy 0 trials · 2 incl. sub-types Sub-types →
- Autosomal dominant titinopathy 0 trials Sub-types →
-
Qualitative or quantitative defects of gamma-sarcoglycan 1 trial · 4 incl. sub-types
1 sub-type
-
Hoyeraal-Hreidarsson syndrome 3 trials
-
Riley-Day syndrome 3 trials
-
Bilirubin encephalopathy 3 trials
1 sub-type
- Kernicterus due to isoimmunization 0 trials
-
Familial congenital mirror movements 3 trials
4 sub-types
- Mirror movements 1 and/or agenesis of the corpus callosum 0 trials Sub-types →
- Mirror movements 2 0 trials
- Mirror movements 3 0 trials
- Mirror movements 4 0 trials
-
Pyridoxine-dependent epilepsy 3 trials
2 sub-types
-
Encephalopathy, acute, infection-induced 2 trials · 3 incl. sub-types
1 sub-type
-
TPM2-related myopathy 1 trial · 3 incl. sub-types
2 sub-types
- Central core myopathy 2 trials
- Congenital myopathy 23 0 trials
-
Congenital hydrocephalus 1 trial · 3 incl. sub-types
8 sub-types
- X-linked hydrocephalus with stenosis of the aqueduct of Sylvius 1 trial
- Hydrocephalus, nonsyndromic, autosomal recessive 1 1 trial
- Autosomal recessive hydrocephalus due to congenital stenosis of aqueduct of Sylvius 0 trials
- Congenital communicating hydrocephalus 0 trials
- Congenital non-communicating hydrocephalus 0 trials
- Hydrocephalus, congenital, 3, with brain anomalies 0 trials
- Hydrocephalus, nonsyndromic, autosomal recessive 2 0 trials
- Hydrocephalus-blue sclerae-nephropathy syndrome 0 trials
-
Pontocerebellar hypoplasia 1 trial · 3 incl. sub-types
21 sub-types
- Pontocerebellar hypoplasia type 6 2 trials
- Pontocerebellar hypoplasia type 1 0 trials Sub-types →
- Pontocerebellar hypoplasia type 10 0 trials
- Pontocerebellar hypoplasia type 2 0 trials Sub-types →
- Pontocerebellar hypoplasia type 2E 0 trials
- Pontocerebellar hypoplasia type 3 0 trials
- Pontocerebellar hypoplasia type 4 0 trials
- Pontocerebellar hypoplasia type 5 0 trials
- Pontocerebellar hypoplasia type 7 0 trials
- Pontocerebellar hypoplasia type 8 0 trials
- Pontocerebellar hypoplasia type 9 0 trials
- Pontocerebellar hypoplasia, IIA 17 0 trials
- Pontocerebellar hypoplasia, type 11 0 trials
- Pontocerebellar hypoplasia, type 12 0 trials
- Pontocerebellar hypoplasia, type 13 0 trials
- Pontocerebellar hypoplasia, type 14 0 trials
- Pontocerebellar hypoplasia, type 15 0 trials
- Pontocerebellar hypoplasia, type 16 0 trials
- Pontocerebellar hypoplasia, type 1D 0 trials
- Pontocerebellar hypoplasia, type 1E 0 trials
- Pontocerebellar hypoplasia, type 1F 0 trials
-
Familial porencephaly 0 trials · 3 incl. sub-types
7 sub-types
- Brain small vessel disease 1 with or without ocular anomalies 3 trials
- Brain small vessel disease 2A, autosomal dominant 1 trial
- Brain small vessel disease 2B, autosomal recessive 0 trials
- Brain small vessel disease 3 0 trials
- Brain small vessel disease 4 0 trials
- Brain small vessel disease 5 with osteoporosis 0 trials
- Brain small vessel disease 6 with leukoencephalopathy 0 trials
-
Inherited reflex epilepsy 0 trials · 3 incl. sub-types
2 sub-types
- Photosensitive epilepsy 1 trial · 2 incl. sub-types Sub-types →
- Hot water reflex epilepsy 1 trial Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin 0 trials · 3 incl. sub-types
4 sub-types
-
Qualitative or quantitative defects of alpha-sarcoglycan 0 trials · 3 incl. sub-types
1 sub-type
-
Chiari malformation type II 2 trials
-
Central nervous system lupus 2 trials
-
Choroid plexus papilloma 2 trials
-
Hereditary retinoblastoma 2 trials
-
1 sub-type
-
Childhood-onset nemaline myopathy 1 trial · 2 incl. sub-types
6 sub-types
- Nemaline myopathy 6 1 trial
- Congenital myopathy 23 0 trials
- Congenital myopathy 2a, typical, autosomal dominant 0 trials
- Congenital myopathy 4B, autosomal recessive 0 trials
- Nemaline myopathy 2 0 trials
- Nemaline myopathy 9 0 trials
-
ATP1A3-associated neurological disorder 0 trials · 2 incl. sub-types
4 sub-types
-
PAX6-related ocular dysgenesis 0 trials · 2 incl. sub-types
2 sub-types
- Isolated optic nerve hypoplasia 2 trials
- Foveal hypoplasia 1 0 trials
-
SPAST-related motor disorder 0 trials · 2 incl. sub-types
1 sub-type
- Hereditary spastic paraplegia 4 2 trials
-
Leukoencephalopathy, megalencephalic 0 trials · 2 incl. sub-types
-
Qualitative or quantitative defects of delta-sarcoglycan 0 trials · 2 incl. sub-types
2 sub-types
-
Retinal ciliopathy 0 trials · 2 incl. sub-types
9 sub-types
- Leber congenital amaurosis 10 2 trials
- Leber congenital amaurosis with early-onset deafness 0 trials
- Cone-rod dystrophy 16 0 trials
- Retinitis pigmentosa 23 0 trials
- Retinitis pigmentosa 51 0 trials
- Retinitis pigmentosa 55 0 trials
- Retinitis pigmentosa 64 0 trials
- Retinitis pigmentosa 74 0 trials
- Retinitis pigmentosa 80 0 trials
-
Brown syndrome 1 trial
-
TPM3-related myopathy 1 trial
3 sub-types
- Cap myopathy 0 trials
- Congenital myopathy 4A, autosomal dominant 0 trials
- Congenital myopathy 4B, autosomal recessive 0 trials
-
Anencephaly 1 trial
4 sub-types
- Anencephaly 1 0 trials
- Anencephaly 2 0 trials
- Hydranencephaly 0 trials Sub-types →
- Isolated anencephaly 0 trials
-
10 sub-types
- Basal ganglia calcification, idiopathic, 1 0 trials
- Basal ganglia calcification, idiopathic, 10, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, 11, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, 4 0 trials
- Basal ganglia calcification, idiopathic, 5 0 trials
- Basal ganglia calcification, idiopathic, 6 0 trials
- Basal ganglia calcification, idiopathic, 7, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, 8, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, 9, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, childhood-onset 0 trials
-
Coloboma of optic nerve 1 trial
1 sub-type
- Morning glory syndrome 0 trials
-
Dilated cardiomyopathy 3B 1 trial
-
Familial meningioma 1 trial
-
5 sub-types
- Cerebral cavernous malformation 1 1 trial
- Cerebral cavernous malformation 2 0 trials
- Cerebral cavernous malformation 3 0 trials
- Cerebral cavernous malformation 4 0 trials
- Cerebral cavernous malformations 5 0 trials
-
Iris hypoplasia with glaucoma 1 trial
-
Linear nevus sebaceous syndrome 1 trial
-
Multiminicore myopathy 1 trial
5 sub-types
- Rigid spine muscular dystrophy 1 1 trial Sub-types →
- Antenatal multiminicore disease with arthrogryposis multiplex congenita 0 trials
- Classic multiminicore myopathy 0 trials
- Congenital multicore myopathy with external ophthalmoplegia 0 trials
- Moderate multiminicore disease with hand involvement 0 trials
-
Myoclonus, familial 1 trial
2 sub-types
- Myoclonus, familial, 1 0 trials
- Myoclonus, familial, 2 0 trials
-
Neurocutaneous melanocytosis 1 trial
-
2-hydroxyglutaric aciduria 0 trials · 1 incl. sub-types
3 sub-types
- D,L-2-hydroxyglutaric aciduria 1 trial
- D-2-hydroxyglutaric aciduria 0 trials Sub-types →
- L-2-hydroxyglutaric aciduria 0 trials
-
PRRT2-associated paroxysmal movement disorder 0 trials · 1 incl. sub-types
3 sub-types
- Episodic kinesigenic dyskinesia 1 1 trial
- Infantile convulsions and choreoathetosis 0 trials
- Seizures, benign familial infantile, 2 0 trials
-
Familial hemiplegic migraine 0 trials · 1 incl. sub-types
5 sub-types
-
Familial periodic paralysis 0 trials · 1 incl. sub-types
6 sub-types
- Hyperkalemic periodic paralysis 1 trial
- Hypokalemic periodic paralysis 1 trial Sub-types →
- Andersen-Tawil syndrome 0 trials
- Normokalemic periodic paralysis 0 trials
- Periodic paralysis with later-onset distal motor neuropathy 0 trials
- Thyrotoxic periodic paralysis 0 trials
-
Myopathy caused by variation in POMGNT1 0 trials · 1 incl. sub-types
-
Neuromuscular disease caused by qualitative or quantitative defects of plectin 0 trials · 1 incl. sub-types
2 sub-types
-
Neuromuscular disease caused by qualitative or quantitative defects of telethonin 0 trials · 1 incl. sub-types
2 sub-types
-
Qualitative or quantitative defects of desmin 0 trials · 1 incl. sub-types
5 sub-types
- Rigid spine syndrome 0 trials · 1 incl. sub-types Sub-types →
- Autosomal dominant limb-girdle muscular dystrophy type 1E (DES) 0 trials
- Dilated cardiomyopathy 1I 0 trials
- Myofibrillar myopathy 1 0 trials
- Neurogenic scapuloperoneal syndrome, Kaeser type 0 trials
-
Severe congenital nemaline myopathy 0 trials · 1 incl. sub-types
5 sub-types
- Nemaline myopathy 8 1 trial
- Congenital myopathy 2a, typical, autosomal dominant 0 trials
- Nemaline myopathy 10 0 trials
- Nemaline myopathy 2 0 trials
- Nemaline myopathy 9 0 trials
-
Bailey-Bloch congenital myopathy 0 trials
-
Behr syndrome 0 trials
-
Behrens Baumann dust syndrome 0 trials
-
Brody myopathy 0 trials
-
DHDDS-related syndrome 0 trials
2 sub-types
-
Frey syndrome 0 trials
-
Griscelli syndrome type 1 0 trials
-
HSD10 mitochondrial disease 0 trials
3 sub-types
- HSD10 disease, atypical type 0 trials
- HSD10 disease, infantile type 0 trials
- HSD10 disease, neonatal type 0 trials
-
Johanson-Blizzard syndrome 0 trials
-
KIF5A-related neurological disorder 0 trials
3 sub-types
-
NPHP3-related Meckel-like syndrome 0 trials
-
PEHO-like syndrome 0 trials
-
PrP systemic amyloidosis 0 trials
-
Prader-Willi-like syndrome 0 trials
3 sub-types
- 6q16 deletion syndrome 0 trials
- BDV syndrome 0 trials
- SIM1-related Prader-Willi-like syndrome 0 trials
-
Ritscher-Schinzel syndrome 0 trials
4 sub-types
- Ritscher-Schinzel syndrome 1 0 trials
- Ritscher-Schinzel syndrome 2 0 trials
- Ritscher-Schinzel syndrome 3 0 trials
- Ritscher-Schinzel syndrome 4 0 trials
-
SERAC1-related neurological disorder 0 trials
-
SLC39A8-CDG 0 trials
-
2 sub-types
-
TUBB3-related tubulinopathy 0 trials
-
Uner Tan Syndrome 0 trials
-
VPS11-related neurological disorder 0 trials
2 sub-types
- Dystonia 32 0 trials
- Hypomyelinating leukodystrophy 12 0 trials
-
X-linked immunoneurologic disorder 0 trials
-
Achromatopsia 6 0 trials
-
Adult-onset nemaline myopathy 0 trials
-
Age-related hearing impairment 1 0 trials
-
Age-related hearing impairment 2 0 trials
-
Alpha-actinopathy 0 trials
4 sub-types
- Cap myopathy 0 trials
- Congenital myopathy 2a, typical, autosomal dominant 0 trials
- Progressive scapulohumeroperoneal distal myopathy 0 trials
- Zebra body myopathy 0 trials
-
Angioid streaks 0 trials
1 sub-type
- Angioid streaks of choroid 0 trials
-
Aniridia 2 0 trials
-
Aniridia 3 0 trials
-
Band heterotopia of brain 0 trials
-
Benign familial infantile epilepsy 0 trials
5 sub-types
-
Benign neonatal seizures 0 trials
4 sub-types
-
Bilateral generalized polymicrogyria 0 trials
-
Blue color blindness 0 trials
-
Bradyopsia 0 trials
2 sub-types
-
Brain-lung-thyroid syndrome 0 trials
-
Caveolinopathy 0 trials
1 sub-type
-
Cerebellar-facial-dental syndrome 0 trials
-
Choreoathetosis, familial inverted 0 trials
-
Cluster headache, familial 0 trials
-
12 sub-types
- Complex cortical dysplasia with other brain malformations 1 0 trials
- Complex cortical dysplasia with other brain malformations 2 0 trials
- Complex cortical dysplasia with other brain malformations 3 0 trials
- Complex cortical dysplasia with other brain malformations 4 0 trials
- Complex cortical dysplasia with other brain malformations 5 0 trials
- Complex cortical dysplasia with other brain malformations 6 0 trials
- Complex cortical dysplasia with other brain malformations 7 0 trials
- Cortical dysplasia, complex, with other brain malformations 10 0 trials
- Cortical dysplasia, complex, with other brain malformations 11 0 trials
- Cortical dysplasia, complex, with other brain malformations 12 0 trials
- Cortical dysplasia, complex, with other brain malformations 9 0 trials
- Polymicrogyria with optic nerve hypoplasia 0 trials
-
Encephalopathy, acute transient 0 trials
-
Epilepsy, familial adult myoclonic 0 trials
8 sub-types
- Benign adult familial myoclonic epilepsy 0 trials
- Epilepsy, familial adult myoclonic, 1 0 trials
- Epilepsy, familial adult myoclonic, 2 0 trials
- Epilepsy, familial adult myoclonic, 3 0 trials
- Epilepsy, familial adult myoclonic, 4 0 trials
- Epilepsy, familial adult myoclonic, 5 0 trials
- Epilepsy, familial adult myoclonic, 6 0 trials
- Epilepsy, familial adult myoclonic, 7 0 trials
-
Familial hyperprolactinemia 0 trials
-
Familial panic disorder 0 trials
3 sub-types
- Panic disorder 1 0 trials
- Panic disorder 2 0 trials
- Panic disorder 3 0 trials
-
Familial schizencephaly 0 trials
-
Familial syringomyelia 0 trials
-
Febrile seizures, familial, 11 0 trials
-
Folinic acid-responsive seizures 0 trials
-
Glycine encephalopathy 0 trials
5 sub-types
- Atypical glycine encephalopathy 0 trials
- Glycine encephalopathy 1 0 trials
- Glycine encephalopathy 2 0 trials
- Infantile glycine encephalopathy 0 trials
- Neonatal glycine encephalopathy 0 trials
-
Hereditary hyperekplexia 0 trials
5 sub-types
- Developmental and epileptic encephalopathy, 8 0 trials
- Hyperekplexia 1 0 trials
- Hyperekplexia 2 0 trials
- Hyperekplexia 3 0 trials
- Hyperekplexia 4 0 trials
-
Holoprosencephaly 0 trials
17 sub-types
- Alobar holoprosencephaly 0 trials Sub-types →
- Chromosome 1q41-q42 deletion syndrome 0 trials
- Holoprosencephaly 1 0 trials
- Holoprosencephaly 10 0 trials
- Holoprosencephaly 11 0 trials
- Holoprosencephaly 12 with or without pancreatic agenesis 0 trials
- Holoprosencephaly 13, X-linked 0 trials
- Holoprosencephaly 14 0 trials
- Holoprosencephaly 2 0 trials
- Holoprosencephaly 3 0 trials Sub-types →
- Holoprosencephaly 4 0 trials
- Holoprosencephaly 6 0 trials
- Holoprosencephaly 7 0 trials
- Holoprosencephaly 8 0 trials
- Lobar holoprosencephaly 0 trials Sub-types →
- Microform holoprosencephaly 0 trials Sub-types →
- Semilobar holoprosencephaly 0 trials
-
Hyperlexia 0 trials
-
Hypermanganesemia with dystonia 2 0 trials
-
Lateral meningocele syndrome 0 trials
-
Lissencephaly spectrum disorders 0 trials
14 sub-types
- Baraitser-Winter cerebrofrontofacial syndrome 0 trials Sub-types →
- Warburg micro syndrome 0 trials Sub-types →
- X-linked lissencephaly with abnormal genitalia 0 trials
- Classic lissencephaly 0 trials Sub-types →
- Cobblestone lissencephaly 0 trials Sub-types →
- Craniotelencephalic dysplasia 0 trials
- Lissencephaly 10 0 trials
- Lissencephaly 7 with cerebellar hypoplasia 0 trials
- Lissencephaly 8 0 trials
- Lissencephaly spectrum disorder with complex brainstem malformation 0 trials Sub-types →
- Lissencephaly type 3 0 trials Sub-types →
- Lissencephaly with cerebellar hypoplasia 0 trials Sub-types →
- Massa casaer ceulemans syndrome 0 trials
- Microlissencephaly 0 trials Sub-types →
-
Major affective disorder 1 0 trials
-
Major affective disorder 2 0 trials
-
Major affective disorder 3 0 trials
-
Major affective disorder 4 0 trials
-
Major affective disorder 5 0 trials
-
Major affective disorder 7 0 trials
-
Major affective disorder 8 0 trials
-
Major affective disorder 9 0 trials
-
Myofibrillar myopathy 5 0 trials
-
Myopic macular degeneration 0 trials
-
Myosclerosis 0 trials
-
Narcolepsy 3 0 trials
-
Narcolepsy 7 0 trials
-
2 sub-types
-
3 sub-types
- MYH7-related skeletal myopathy 0 trials
- Congenital myopathy 7A, myosin storage, autosomal dominant 0 trials
- Hyaline body myopathy 0 trials
-
2 sub-types
-
Neuroocular syndrome 0 trials
2 sub-types
-
Oculocerebrocutaneous syndrome 0 trials
-
Orofaciodigital syndrome type 6 0 trials
-
Parietal foramina 0 trials
3 sub-types
- Parietal foramina 1 0 trials
- Parietal foramina 2 0 trials
- Parietal foramina 3 0 trials
-
Parkinsonism with polyneuropathy 0 trials
-
Paroxysmal extreme pain disorder 0 trials
-
Periventricular nodular heterotopia 0 trials
8 sub-types
- Chromosome 5Q14.3 deletion syndrome, distal 0 trials
- Heterotopia, periventricular, X-linked dominant 0 trials
- Heterotopia, periventricular, associated with chromosome 5P anomalies 0 trials
- Periventricular heterotopia with microcephaly, autosomal recessive 0 trials
- Periventricular nodular heterotopia 6 0 trials
- Periventricular nodular heterotopia 7 0 trials
- Periventricular nodular heterotopia 8 0 trials
- Periventricular nodular heterotopia 9 0 trials
-
Phakomatosis pigmentokeratotica 0 trials
-
Prosopagnosia, hereditary 0 trials
-
Red color blindness 0 trials
-
Schizophrenia 15 0 trials
-
Schizophrenia 16 0 trials
-
Schizophrenia 19 0 trials
-
Typical nemaline myopathy 0 trials
6 sub-types
- Congenital myopathy 23 0 trials
- Congenital myopathy 2a, typical, autosomal dominant 0 trials
- Nemaline myopathy 10 0 trials
- Nemaline myopathy 2 0 trials
- Nemaline myopathy 7 0 trials
- Nemaline myopathy 9 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 1124 trials in this tab.
-
Can a One-Time gene therapy fix the root cause of rett syndrome?
Cure By invitation onlyRett syndrome is a rare genetic disorder that mostly affects girls and stems from mutations in the MECP2 gene. This trial tests GCB-002, an experimental gene therapy given as a single injection into the spinal fluid, in 6 to 9 girls aged 2 to 10 who have a confirmed MECP2 mutatio…
Sponsor: Genecombio Ltd. • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC
-
One-Time gene therapy for fatal childhood brain disease: does it last?
Cure OngoingResearchers are following 64 people with cerebral adrenoleukodystrophy (CALD) for 15 years after they received a one-time gene therapy called eli-cel in earlier studies. The therapy uses the patient's own stem cells, modified to carry a working copy of the gene that is faulty in …
Sponsor: Genetix Biotherapeutics Inc. • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
One-Shot gene therapy aims to restore movement in children with SMA
Cure By invitation onlyResearchers test GCB-001, a gene therapy given as a single injection into the spinal fluid, in children aged 2 to 12 with type 2 spinal muscular atrophy who can sit alone but cannot walk. The trial checks safety and whether the treatment improves motor skills over 12 months. It i…
Sponsor: Genecombio Ltd. • Aim: Cure
Last updated Sep 13, 2026 00:00 UTC
-
One-Time injection aims to restore hearing in children born deaf
Cure OngoingThis trial tests a gene therapy called SENS-501 for children aged 6 to 31 months who are severely or profoundly deaf due to mutations in the otoferlin gene. The therapy is injected directly into one inner ear to deliver a working copy of the gene. The goal is to restore natural h…
Phase 1/2 • Sponsor: Sensorion • Aim: Cure
Last updated Jul 10, 2026 00:00 UTC
-
New drug aims to stop brain bleeds in rare disease
Disease control OngoingThis study tests an experimental drug called ALN-APP in 200 adults with cerebral amyloid angiopathy (CAA), a condition that causes bleeding in the brain. The drug is given via spinal injection and aims to slow disease progression and reduce new brain bleeds. Participants will be …
Phase 2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Brain pacemaker tested for Musician's hand cramps
Disease control OngoingThis study tests deep brain stimulation (DBS) surgery for people with severe focal hand dystonia, including musician's dystonia, that hasn't improved with botulinum toxin. Five participants will have electrodes placed in brain areas that control movement, connected to a stimulato…
Phase 1/2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Immunotherapy combo shows promise in preventing High-Risk uterine cancer return
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (with or without radiation) after surgery can help prevent high-risk endometrial cancer from coming back. About 990 participants who had surgery to remove their uterus and ovaries will r…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Higher-Dose eye injection shows promise for two leading causes of vision loss
Disease control OngoingThis study tests a higher dose of the drug aflibercept (8 mg) given as an eye injection every 4 weeks to people with wet age-related macular degeneration (nAMD) or diabetic macular edema (DME). The goal is to see if this dosing schedule is safe and works well for those who have a…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New gene therapy targets Parkinson's in patients with specific gene flaw
Disease control OngoingThis study tests a new gene therapy called LY3884961 in 32 people with moderate to severe Parkinson's disease who have a specific genetic change (GBA1 mutation). The treatment is given as a single injection into the fluid around the brain and spinal cord. The main goal is to chec…
Phase 1/2 • Sponsor: Prevail Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study tests everolimus for kidney tumors in TSC patients
Disease control OngoingThis study looks at how safe and effective the drug everolimus is for Taiwanese adults with tuberous sclerosis complex (TSC) who have kidney tumors called angiomyolipomas. Four participants will take the drug and be monitored for side effects and tumor shrinkage. The goal is to c…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Hope for becker MD: new drug shows promise in Long-Term trial
Disease control By invitation onlyThis study looks at the long-term safety and effects of a drug called EDG-5506 (sevasemten) in people with Becker muscular dystrophy, a muscle-weakening disease. About 260 adults and teens who were in earlier EDG-5506 studies will take the drug and be monitored for side effects a…
Phase 2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New eye injection aims to slow genetic blindness
Disease control OngoingThis study tests a new medicine called PYC-001, given as an injection into the eye, for people with a genetic condition that damages the optic nerve (OPA1 optic atrophy). The main goal is to check if the treatment is safe and tolerable. About 18 adults will receive a single dose,…
Phase 1 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for dravet syndrome: phase 3 trial of LP352 aims to cut seizure frequency
Disease control OngoingThis study tests whether the drug LP352 can safely reduce seizures in children and adults with Dravet syndrome, a severe form of epilepsy. About 160 participants will receive either LP352 or a placebo, and researchers will track changes in seizure frequency over several months. T…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a daily injection save your sight? new trial for dry AMD
Disease control OngoingThis phase 3 trial tests whether a daily injection of elamipretide can slow vision loss in people with dry age-related macular degeneration (AMD). About 313 adults aged 55 and older with early dry AMD will receive either the drug or a placebo for 96 weeks. The main goal is to see…
Phase 3 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Promising drug may shrink inoperable tumors in kids with rare genetic condition
Disease control OngoingThis study tests a drug called selumetinib in children and young adults (ages 3-18) with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink or slow the growth of these tumors. Participants take the dru…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for hard-to-treat lung cancer: experimental drug targets MET gene
Disease control OngoingThis study tests an experimental drug called REGN5093 in people with advanced non-small cell lung cancer that has a specific change in the MET gene. The first part finds a safe dose, and the second part checks if the drug can shrink tumors. About 231 participants will take part.
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Spinal gene injection aims to slow duchenne in toddlers
Disease control OngoingThis early-stage study tests a single injection of a gene therapy called INS1201, given into the spinal fluid of young boys (ages 2 to 5) with Duchenne muscular dystrophy who can still walk. The main goal is to check if the treatment is safe and to see how it spreads in the body.…
Phase 1 • Sponsor: Insmed Gene Therapy LLC • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for Hard-to-Treat seizures: phase 3 trial launches
Disease control OngoingThis study tests an experimental drug called LP352 to see if it can safely reduce seizures in children and adults with developmental and epileptic encephalopathies (DEE), a group of severe epilepsy syndromes. About 320 participants will receive either LP352 or a placebo, and rese…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Parkinson's patients get brain transplants of their own cells
Disease control By invitation onlyThis early-stage trial tests whether transplanting dopamine neurons made from a patient's own stem cells into the brain is safe for Parkinson's disease. Six people aged 55 to 80 with Parkinson's for at least 5 years will receive the cells in a single surgery. The main goal is to …
Phase 1 • Sponsor: Penelope J. Hallett, Ph.D. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for duchenne: experimental drug targets genetic glitch
Disease control OngoingThis study tests an experimental drug called NS-089/NCNP-02 (Brogidirsen) in 20 boys with Duchenne muscular dystrophy whose genetic mutation can be fixed by skipping exon 44. The drug is given as a weekly IV infusion and aims to help the body produce a working version of the dyst…
Phase 2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Brain implant shows promise for Hard-to-Treat seizures in rare epilepsy
Disease control OngoingThis study tests a brain-responsive neurostimulation system in 24 people aged 12 and older with Lennox-Gastaut syndrome whose seizures are not controlled by medication. The device detects and responds to seizure activity in the brain to reduce drop seizures. The goal is to see if…
Phase 2 • Sponsor: NeuroPace • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New antibody aims to block muscle wasting in rare disease
Disease control OngoingThis Phase 2 trial tests a drug called RO7204239 in 51 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes progressive muscle weakness. The drug is an antibody that blocks myostatin, a protein that normally limits muscle growth, to help pres…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill aims to tame rare immune diseases
Disease control OngoingThis early-stage trial tests an experimental drug called BI 3000202 in 16 adults with rare type 1 interferonopathies, such as Aicardi-Goutières syndrome. Participants take a low dose for 4 weeks, then a higher dose for 36 weeks. The main goal is to see if the drug is safe and how…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for NF1 patients: drug shows promise against inoperable tumors
Disease control OngoingThis study tests a drug called selumetinib in adults with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink these tumors or slow their growth. Participants take the drug twice daily and are monitored …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New gene therapy aims to fix immune system in rare disease
Disease control By invitation onlyThis study tests a new gene therapy for people with chronic granulomatous disease (CGD), a genetic disorder that weakens the immune system and makes them prone to serious infections. The treatment takes the patient's own blood stem cells, adds a missing gene in the lab, and puts …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug LP352 aims to control seizures in severe epilepsy over the long term
Disease control By invitation onlyThis phase 3 study is testing the long-term safety and effectiveness of LP352 (Bexicaserin) in 324 children and adults with developmental and epileptic encephalopathy (DEE), including Dravet and Lennox-Gastaut syndromes. Participants who completed earlier studies will receive LP3…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New epilepsy drug XEN1101 tested for long-term seizure control
Disease control By invitation onlyThis study tests the long-term safety and effectiveness of XEN1101 (azetukalner) in 880 adults with focal or tonic-clonic seizures. Participants who completed earlier studies will take XEN1101 capsules for up to 6 years. Researchers will track side effects and changes in monthly …
Phase 3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug cocktail shows promise for tough childhood brain cancers
Disease control OngoingThis trial is testing whether adding hydroxychloroquine to two targeted cancer drugs (dabrafenib and trametinib) can help children and young adults with certain brain tumors that have come back or not responded to treatment. The study includes patients with specific genetic chang…
Phase 1/2 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New eye injection aims to slow vision loss from Age-Related macular degeneration
Disease control OngoingThis study tests the safety of a drug called ASP3021 (avacincaptad pegol) for people in Japan with geographic atrophy, an advanced form of age-related macular degeneration that causes vision loss. Twenty participants will receive monthly injections into the affected eye for 12 mo…
Phase 4 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could an antibody slow Parkinson's? new trial hopes to find out
Disease control OngoingThis study tests an experimental drug called prasinezumab in 316 people with early Parkinson's disease. The drug is an antibody designed to target and remove clumps of a protein linked to Parkinson's. Participants receive either the drug or a placebo for 52 weeks, with an option …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Gene therapy hope for duchenne boys in first human test
Disease control OngoingThis early-stage trial tests a single dose of a gene therapy called JWK007 in 3 boys aged 5-10 with Duchenne muscular dystrophy. The main goal is to check safety and tolerability, while also looking at whether it helps muscle function. It is a very small, first-in-human study, so…
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Gene therapy shot could end frequent eye injections for wet AMD
Disease control OngoingThis early-stage trial tests a one-time gene therapy injection (NG101) for wet age-related macular degeneration. The therapy uses a harmless virus to deliver a gene that makes a drug inside the eye, aiming to reduce the need for repeated anti-VEGF injections. About 20 adults aged…
Phase 1/2 • Sponsor: Elisigen, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New combo shows promise for rare adrenal cancers
Disease control OngoingThis study tests whether adding olaparib to the standard chemotherapy temozolomide helps control advanced pheochromocytoma or paraganglioma—rare neuroendocrine tumors that have spread or can't be removed surgically. About 46 adults with these cancers will be randomly assigned to …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could skipping Face-Down recovery be safe for macular hole surgery?
Disease control OngoingThis trial tests whether people with large macular holes (over 400 micrometres) can heal without the usual face-down positioning after surgery. All participants undergo a procedure called inverted flap vitrectomy with gas tamponade, and half are asked to avoid face-down posturing…
Sponsor: Lahore General Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Brain implant that learns: new hope for Parkinson's?
Disease control OngoingThis study tests an adaptive deep brain stimulation (aDBS) system that automatically adjusts stimulation based on real-time brain signals. It aims to improve symptom control for 62 people with Parkinson's disease in China who already have a compatible brain implant. The main goal…
Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Lung cancer hope: drug combo aims to boost survival in Early-Stage disease
Disease control OngoingThis phase 3 trial tests whether adding pembrolizumab (an immunotherapy) and olaparib (a targeted drug) to standard chemotherapy and radiation can help people with limited-stage small cell lung cancer live longer. About 672 participants will receive either the drug combo or a pla…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Hope for rare muscle disease: new drug enters final testing phase
Disease control OngoingThis study tests a drug called BBP-418 (Ribitol) in 81 people aged 12 to 60 with limb girdle muscular dystrophy type 2I (LGMD2I), a genetic condition that causes progressive muscle weakness. Participants receive either the drug or a placebo for 36 months to see if it slows the di…
Phase 3 • Sponsor: ML Bio Solutions, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for angelman syndrome: experimental drug enters Mid-Stage trial
Disease control OngoingThis study tests an experimental drug called GTX-102 (apazunersen) in 60 people with Angelman syndrome, a genetic disorder causing developmental delays and seizures. Participants range from 1 to 65 years old and are grouped by age and genetic type. The goal is to see if the drug …
Phase 2 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
SMA drug risdiplam under Long-Term watch: will it hold up?
Disease control OngoingThis study follows 403 adults and children with spinal muscular atrophy who are already taking risdiplam (Evrysdi) as prescribed by their doctor. Researchers will track side effects and how well the drug works over about two years. The goal is to see if risdiplam remains safe and…
Phase 4 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug aims to control angelman syndrome long-term
Disease control OngoingThis phase 3 trial tests the long-term safety of GTX-102 (apazunersen) in 255 people with Angelman syndrome, a genetic disorder causing developmental delays and seizures. Participants have already completed an earlier GTX-102 study and will continue receiving the drug. The main g…
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New Muscle-Boosting drug combo tested for SMA
Disease control OngoingThis study tests whether adding an experimental drug (RO7204239) to an existing SMA medicine (risdiplam) can help people with spinal muscular atrophy build stronger muscles and move better. The trial includes about 259 children and young adults, ages 2 to 25, who can walk. Resear…
Phase 2/3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Gene therapy trial targets duchenne in toddlers
Disease control OngoingThis study tests a gene therapy called delandistrogene moxeparvovec in 13 children under age 4 with Duchenne muscular dystrophy. The goal is to see if it is safe and can help produce a key muscle protein. The children will be followed for about 5 years.
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for men with Hard-to-Treat prostate cancer?
Disease control OngoingThis phase 3 trial compares a new drug, BMS-986365, against standard treatments (docetaxel or other hormone therapies) in 960 men with metastatic castration-resistant prostate cancer that has stopped responding to hormone therapy. The main goal is to see if the new drug delays ca…
Phase 3 • Sponsor: Celgene • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New vaccine combo aims to slow Alzheimer's by targeting tau tangles
Disease control By invitation onlyThis study tests a vaccine called AADvac1, which targets tau tangles in the brain, a hallmark of Alzheimer's. It will be given alone or with another drug (donanemab) to 450 adults aged 50-80 with very early Alzheimer's. The goal is to see if this approach can reduce tau buildup a…
Phase 2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a short pill course save hand function in advanced MS?
Disease control OngoingThis UK trial tests whether cladribine tablets, taken for just 8-10 days a year over two years, can slow the loss of hand function in people with advanced multiple sclerosis (MS). The study includes 204 participants with significant disability (EDSS 6.5-8.5). Half receive cladrib…
Phase 2/3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a brain implant let paralyzed people control computers with their minds?
Disease control OngoingThis study tests a device called a motor neuroprosthesis, an implantable brain computer interface designed to help people with severe paralysis control digital devices like computers or tablets. The device aims to bypass damaged motor pathways and transmit brain signals directly …
Sponsor: Synchron Medical, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could an arthritis drug help kids with duchenne MD? new trial aims to find out
Disease control OngoingThis study tests satralizumab, a drug that calms inflammation, in 30 children aged 8 to 17 with Duchenne muscular dystrophy. The goal is to see if it improves bone density and muscle function. Participants receive injections for several months while continuing standard steroid th…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug aims to slow Parkinson's progression in early stages
Disease control OngoingThis phase 2 trial tests whether prasinezumab, given as an IV infusion every 4 weeks, can slow motor decline in people with early Parkinson's disease. The study includes 586 participants who are already on stable Parkinson's medication. Researchers are measuring how long it takes…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New eye drug could slash injection frequency for wet AMD patients
Disease control OngoingThis phase 3 trial tests EYP-1901, a new eye injection that may last longer than current treatments for wet age-related macular degeneration (AMD). About 400 participants will receive either EYP-1901 or the standard drug aflibercept. The goal is to see if EYP-1901 can maintain or…
Phase 3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New eye drug aims to cut injection frequency for wet AMD patients
Disease control OngoingThis phase 3 trial tests EYP-1901, a new eye injection that may last longer than current treatments for wet age-related macular degeneration (AMD). About 400 people with wet AMD will receive either EYP-1901 or standard aflibercept injections over 2 years. The main goal is to see …
Phase 3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a leukemia drug slow Parkinson's disease?
Disease control OngoingResearchers are testing whether radotinib, a drug used for leukemia, can help people with Parkinson's disease. The trial will give the drug or a placebo to about 43 adults aged 40 to 80 who were diagnosed within the past three years. The study measures safety, how the drug moves …
Phase 2 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Children's trial launches for Friedreich's ataxia drug
Disease control OngoingThis study tests omaveloxolone, a drug already approved for adults with Friedreich's ataxia, in children aged 2 to 15. Researchers want to see how the drug moves through children's bodies and whether it is safe. The study involves two parts: a single dose followed by daily dosing…
Phase 1 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New Huntington's drug enters first human tests
Disease control OngoingThis early-stage study tests a new drug called RG6496 in people who carry the gene for Huntington's disease. The main goal is to check if the drug is safe and how the body handles it. About 40 participants will receive a single dose injected into the spine, with some getting a pl…
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Sound waves aimed at the brain: a new approach to OCD?
Disease control OngoingThis trial tests whether low intensity focused ultrasound (LIFU), a non-invasive technique that uses sound waves to stimulate deep brain regions, can safely ease symptoms of obsessive-compulsive disorder (OCD). Researchers will target the ventral striatum, an area linked to OCD, …
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a brain implant learn to sense OCD distress and respond in real time?
Disease control OngoingThis trial tests an adaptive deep brain stimulation system for people with severe obsessive-compulsive disorder (OCD) that has not improved with standard treatments. The device, implanted in the brain, aims to detect brain signals linked to OCD distress and adjust its stimulation…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called MK-2870, either alone or with the immunotherapy pembrolizumab, in Japanese patients with advanced solid tumors or a type of lung cancer. The main goal is to check the safety and side effects of these treatments. About 30 people will …
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Which DBS setting works best for Parkinson's? a trial puts anodic vs cathodic to the test
Disease control OngoingThis trial tests three deep brain stimulation (DBS) settings in people with Parkinson's disease who already have a Boston Scientific Vercise system implanted. The settings are pure anodic, pure cathodic, and a mix of both. Researchers want to see which setting offers the best sym…
Sponsor: University of South Florida • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a single gene therapy calm Parkinson's for years?
Disease control OngoingThis study follows people with Parkinson's disease who previously received AAV-GAD, a gene therapy infused into a brain region that helps control movement. The goal is to check how safe the treatment remains over many years, watching for any drug-related side effects. Researchers…
Phase 1/2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could brain pacemakers slow Alzheimer's? new trial tests DBS
Disease control By invitation onlyThis study tests whether deep brain stimulation (DBS) can improve thinking and memory in people with early Alzheimer's disease. Two participants will have electrodes implanted in a brain area that produces a key chemical for memory. The goal is to see if daily, one-hour stimulati…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Eye implant could replace monthly shots for blinding disease
Disease control OngoingThis study tests a small, refillable implant placed in the eye that slowly releases medication for wet age-related macular degeneration (nAMD). It aims to see if refilling the implant every 24 weeks works as well as getting a standard eye injection every 4 weeks. About 68 Chinese…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for advanced stomach cancer: experimental combo targets HER2-positive tumors
Disease control OngoingThis study tests whether a new drug called zanidatamab, combined with chemotherapy and sometimes another drug (tislelizumab), works better than the current standard treatment for advanced HER2-positive stomach and esophageal cancers. About 920 adults whose cancer has spread or ca…
Phase 3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug cocktail shows promise for rare cancers
Disease control OngoingThis phase 2 trial is testing whether a combination of two drugs, talazoparib and temozolomide, can shrink tumors in people with rare cancers that have spread. The study includes 14 participants with advanced rare solid tumors, such as pheochromocytoma or paraganglioma, who have …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a muscle-boosting antibody help people with spinal muscular atrophy over the long haul?
Disease control OngoingThis trial tests the long-term safety and effectiveness of apitegromab, an investigational antibody that blocks myostatin, a protein that limits muscle growth. People with type 2 or type 3 spinal muscular atrophy who completed earlier apitegromab studies can join. Researchers wil…
Phase 3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could your own nerves help treat Parkinson's? early trial tests idea
Disease control OngoingThis study is testing whether implanting a small piece of a patient's own nerve tissue into the brain during deep brain stimulation (DBS) surgery is safe and doable for people with Parkinson's disease. The nerve tissue contains cells that produce growth factors, which might help …
Phase 1 • Sponsor: Craig van Horne, MD, PhD • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could your own nerves help heal Parkinson's? small trial begins
Disease control OngoingThis early-stage trial tests whether implanting a small piece of a patient's own nerve tissue into the brain during deep brain stimulation (DBS) surgery is safe and feasible. Ten people with Parkinson's disease will receive the implant, and researchers will monitor them for a yea…
Phase 1 • Sponsor: Craig van Horne, MD, PhD • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Heart cell therapy shows promise for duchenne MD in major trial
Disease control OngoingThis Phase 3 trial tests a cell therapy called deramiocel (CAP-1002) in 106 boys and young men with Duchenne muscular dystrophy. Participants receive either the cell therapy or a placebo every 3 months for a year, then all can receive the therapy for another year. The goal is to …
Phase 3 • Sponsor: Capricor Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a tiny implant replace monthly eye shots for wet AMD?
Disease control OngoingThis study tests an experimental implant (AR-14034) that slowly releases medication inside the eye to treat wet age-related macular degeneration (AMD). The goal is to see if it is safe and can work as well as or better than standard anti-VEGF injections, which require frequent do…
Phase 1/2 • Sponsor: Alcon Research • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New study tests gentler brain surgery for older patients
Disease control CancelledThis study compares two surgical approaches for treating idiopathic normal pressure hydrocephalus (iNPH) in people aged 60 and older. One group will receive standard ventriculoperitoneal shunt surgery under general anesthesia, while the other will receive a lumbar-peritoneal shun…
Phase 4 • Sponsor: Institute for Clinical Effectiveness, Japan • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New hope for muscle disease: experimental drug VX-670 enters human trials
Disease control OngoingThis early-stage trial tests the safety and tolerability of a new drug called VX-670 in 52 adults with myotonic dystrophy type 1 (DM1), a genetic condition that causes muscle weakness and other problems. Participants receive either VX-670 or a placebo, and researchers will monito…
Phase 1/2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Gene therapy hope for toddlers with rett syndrome
Disease control OngoingThis study tests a one-time gene therapy called TSHA-102 in girls aged 2 to 4 with Rett syndrome, a severe genetic disorder. The therapy is given as a single injection into the spine. The main goal is to check if it is safe and tolerable, and to see early signs of whether it help…
Phase 3 • Sponsor: Taysha Gene Therapies, Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New granule drug could ease tumors in toddlers with NF1
Disease control OngoingThis study tests a granule (sprinkle) form of the drug selumetinib in children aged 1 to under 7 years who have neurofibromatosis type 1 (NF1) with painful, inoperable tumors. The goal is to find the right dose, check safety, and see if it shrinks tumors. About 36 children will t…
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new drug help boys with duchenne muscular dystrophy build muscle protein?
Disease control OngoingThis trial is testing an investigational drug called DYNE-251 in boys with Duchenne muscular dystrophy (DMD) who have a specific genetic mutation. The goal is to see if the drug can safely help their muscles produce dystrophin, a protein that is missing in DMD. Participants recei…
Phase 1/2 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Gene therapy trial aims to slow duchenne muscular dystrophy in boys
Disease control OngoingThis study tests a single dose of SGT-001 gene therapy in 12 boys (children and teens) with Duchenne muscular dystrophy. The main goal is to check safety and how well the body tolerates the treatment. Participants will be followed for about 5 years to monitor side effects and any…
Phase 1/2 • Sponsor: Solid Biosciences Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could your own bone marrow cells help fight Parkinson's?
Disease control OngoingThis early-stage trial is testing whether a single same-day treatment using a patient's own bone marrow cells is safe and tolerable for people with Parkinson's disease or related conditions. The procedure involves drawing bone marrow from the hip, giving one portion through an IV…
Phase 1/2 • Sponsor: Apeiron Research Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug hopes to boost brain function in kids with rare genetic disorder
Disease control OngoingThis Phase 3 trial tests a drug called GTX-102 (apazunersen) in 129 children with Angelman syndrome, a genetic condition causing severe developmental delays. The study compares the drug to a sham procedure to see if it improves cognitive function and other symptoms over about 11 …
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can invisible electric fields quiet the Brain's seizure signals?
Disease control By invitation onlyThis trial tests whether a non-invasive technique called temporally-interfering electric field stimulation (TIEFS) can reduce abnormal brain activity linked to epilepsy. Researchers will measure seizure-related signals in patients with medial temporal lobe epilepsy who are alread…
Sponsor: University of California, Davis • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for kids with rare epilepsy: drug trial targets seizure control
Disease control OngoingThis study tests an investigational drug called relutrigine in 160 children with a severe form of epilepsy called developmental and epileptic encephalopathy (DEE). The goal is to see if the drug can safely reduce monthly seizure frequency compared to a placebo. After the initial …
Phase 3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
CRISPR therapy shows promise in early trial for fatal muscle disease
Disease control OngoingThis early-phase study tested a new gene editing treatment called HG302 in 4 boys with Duchenne muscular dystrophy (DMD), a severe muscle-wasting disease. The therapy uses CRISPR technology to fix the genetic error and help muscles produce dystrophin, a protein essential for musc…
Early phase 1 • Sponsor: HuidaGene Therapeutics Co., Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
One-Shot gene therapy could end monthly eye injections for wet AMD
Disease control OngoingThis study tests a one-time gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. About 714 adults aged 50-89 who currently need regular eye injections will receive either the gene therapy or standard treatment. The goal is to…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
A helping hand after burns: could support workers save lives?
Disease control OngoingThis trial tests whether a culturally adapted program of case manager support can improve survival, reduce hospital readmissions, and boost quality of life for adults recovering from accidental burn injuries in Pakistan. Participants receive up to eight sessions with a case manag…
Sponsor: Pakistan Institute of Living and Learning • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New eye drug could cut wet AMD shots to just twice a year
Disease control OngoingThis study tests whether faricimab, an already-approved eye injection, can be given every 24 weeks (about twice a year) to people newly diagnosed with wet age-related macular degeneration (AMD). The trial involves 274 participants and will measure how well vision is maintained ov…
Phase 4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Gene therapy trial aims to restore night vision in rare eye disease
Disease control OngoingThis study tests a gene therapy called OCU400 for people with retinitis pigmentosa, an inherited eye disease that causes vision loss. The treatment is injected under the retina to help light-sensitive cells work better. The trial enrolled 140 people aged 3 and older and measures …
Phase 3 • Sponsor: Ocugen • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Gene therapy trial aims to halt blindness in dry AMD
Disease control OngoingThis study tests a gene therapy called OCU410 for geographic atrophy, a severe form of dry age-related macular degeneration that causes vision loss. About 60 adults aged 50 and older will receive a single injection of OCU410 into the eye. Researchers will monitor safety and check…
Phase 1/2 • Sponsor: Ocugen • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Gene therapy slows vision loss in stargardt disease trial
Disease control OngoingThis study tests a new gene therapy called OCU410ST for people with Stargardt disease, an inherited eye condition that causes vision loss. Early results show the treatment slowed damage to the retina by nearly half and improved or stabilized eyesight in all treated patients. The …
Phase 2/3 • Sponsor: Ocugen • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a targeted infusion slow muscle decline in duchenne? a new trial aims to find out.
Disease control OngoingThis phase 2 trial tests an experimental drug called AOC 1044 in people with Duchenne muscular dystrophy whose genetic mutation makes them candidates for exon 44 skipping therapy. The drug is given by intravenous infusion. Researchers are evaluating long-term safety and whether i…
Phase 2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Hope for rare brain disease: new drug trial aims to stall deadly decline
Disease control OngoingThis Phase 3 study tests whether the drug leriglitazone can help adult men with cerebral adrenoleukodystrophy (cALD), a rare and serious brain disease. The main goal is to see if the drug delays death or the need for permanent breathing support compared to a placebo. About 40 men…
Phase 3 • Sponsor: Minoryx Therapeutics, S.L. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a spinal injection safely slow spinal muscular atrophy? a real-world study in korea seeks answers.
Disease control OngoingThis study tracks the safety and effectiveness of Spinraza (nusinersen) in people with spinal muscular atrophy (SMA) who receive the drug as part of routine care in Korea. Researchers will monitor for side effects and measure changes in motor skills over time. The goal is to see …
Sponsor: Biogen • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a new drug stop inherited Alzheimer's in its tracks?
Disease control OngoingThis study tests lecanemab, an antibody that targets amyloid plaques in the brain, in 40 people who carry a gene mutation that causes early-onset Alzheimer's. Participants previously received another anti-amyloid drug and will now receive lecanemab to see if it can fully clear am…
Phase 3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New drug combo aims to halt Alzheimer's in people with genetic mutation
Disease control OngoingThis study tests whether two drugs, E2814 and lecanemab, can slow the progression of Alzheimer's in people who carry a gene mutation that causes the disease. About 197 participants will receive either the drugs or a placebo over 2 to 4 years. Researchers will measure changes in t…
Phase 2/3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can new drugs delay inherited Alzheimer's? major trial underway
Disease control OngoingThis study tests whether experimental drugs can slow down memory and thinking problems in people who have a gene mutation that causes Alzheimer's disease. About 490 adults aged 18-80 with this genetic risk are taking either a study drug or a placebo. The goal is to see if the dru…
Phase 2/3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Aggressive blood pressure control may fight Alzheimer's in the brain
Disease control OngoingThis study investigates whether intensively lowering systolic blood pressure with FDA-approved medications can reduce the buildup of amyloid and tau proteins in the brain—hallmarks of Alzheimer's disease. The trial enrolls adults aged 60-85 with high blood pressure who are cognit…
Phase 2 • Sponsor: Rong Zhang • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Experimental drug aims to curb brain bleeds in rare genetic disease
Disease control OngoingThis study tests an experimental drug, NPI-001 (AT-001), in people with hereditary cystatin C amyloid angiopathy (HCCAA), a rare genetic condition that causes repeated brain bleeding and stroke. The trial includes about 15 participants aged 12 and older who carry the specific L68…
Phase 2 • Sponsor: Arctic Therapeutics • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug cocktail aims to beat bladder cancer recurrence
Disease control OngoingThis phase 3 trial tests whether a combination of enfortumab vedotin and pembrolizumab, given before and after bladder removal surgery, works better than standard chemotherapy for muscle-invasive bladder cancer. About 800 participants will be randomly assigned to one of the two t…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Gene therapy trial targets inherited dementia
Disease control OngoingThis study tests a single-dose gene therapy called LY3884963 in 35 people with frontotemporal dementia caused by GRN gene mutations. The therapy aims to raise levels of a missing protein (progranulin) in the brain. Participants receive the treatment via injection into the fluid a…
Phase 1/2 • Sponsor: Prevail Therapeutics • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for FSHD: Long-Term drug safety trial underway
Disease control OngoingThis study is for people with FSHD, a genetic disease that causes muscle weakness. It tests the long-term safety and how well the body tolerates a drug called AOC 1020, given through a vein. About 84 adults who completed a previous study will take part. The main goal is to check …
Phase 2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New Dual-Action drug shows promise in early lung cancer trial
Disease control OngoingThis study tests a new drug called rilvegostomig (AZD2936) in people with advanced or metastatic non-small cell lung cancer. The drug is designed to boost the immune system's ability to fight cancer by blocking two targets (TIGIT and PD-1). The trial will check for safety, side e…
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Treadmill training may slow Parkinson's motor decline
Disease control OngoingThis study tests whether high-intensity treadmill exercise can slow the worsening of motor symptoms in people with early-stage Parkinson's disease. 370 participants who have not yet started Parkinson's medication will be assigned to either moderate or high-intensity treadmill ses…
Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a pill replace infusions for gaucher brain symptoms?
Disease control OngoingThis phase 2 trial tests an oral drug called venglustat, given alongside the standard enzyme therapy Cerezyme, in adults with Gaucher disease type 3 (a rare genetic disorder affecting the body and brain). The study has four parts: first, it checks spinal fluid biomarkers to disti…
Phase 2 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug shows promise for shrinking painful NF1 tumors
Disease control OngoingThis study tests a drug called mirdametinib in 114 adults and children with a genetic condition called NF1 that causes nerve tumors (plexiform neurofibromas) that cannot be removed by surgery and cause serious problems. The drug works by blocking a protein that helps tumors grow.…
Phase 2 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Zolgensma's long-term effects under the microscope in new 5-year study
Disease control OngoingThis study follows 175 people with spinal muscular atrophy who previously received the gene therapy Zolgensma in clinical trials. Researchers will monitor them for 5 years to track serious side effects and developmental milestones. The goal is to understand how safe and effective…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New eye injection aims to slow blindness in rare genetic disease
Disease control OngoingThis study tests an experimental drug called ultevursen for people with retinitis pigmentosa caused by a specific gene mutation (USH2A). The drug is injected into the eye and may help slow vision loss. The trial involves 81 participants, some of whom will receive a sham (fake) in…
Phase 2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug shows promise in preventing SMA in newborns
Disease control OngoingThis study tests the drug risdiplam (Evrysdi) in infants up to 6 weeks old who have a genetic diagnosis of spinal muscular atrophy (SMA) but no symptoms yet. The goal is to see if early treatment can help them reach motor milestones like sitting without support. The trial involve…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Hormone blocker aims to pause early puberty in children
Disease control OngoingThis trial tests a long-acting injection of leuprolide acetate in children with central precocious puberty, a condition where puberty starts too early. The goal is to suppress puberty-related hormones, slowing or stopping early development. The study includes children aged 4 to 9…
Phase 4 • Sponsor: HanAll BioPharma Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a blood extract save sight? early trial tests PRP for rare eye diseases
Disease control OngoingThis pilot study tests whether injections of platelet-rich plasma (PRP) made from a patient's own blood can help preserve vision in people with retinitis pigmentosa or a related condition called EMAP. Thirty participants receive three injections over four months, and researchers …
Phase 1/2 • Sponsor: Rubens Camargo Siqueira • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a natural hormone rebuild brains in Alzheimer's?
Disease control OngoingThis phase 2 trial tests whether allopregnanolone, a natural hormone, can safely help repair the brain in people with early Alzheimer's disease. About 100 volunteers aged 55 to 80 will receive weekly infusions of the drug or a placebo for several months. Researchers will measure …
Phase 2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can an arthritis drug save sight? small trial tests adalimumab for rare eye diseases
Disease control OngoingThis pilot study tests whether adalimumab, an anti-inflammatory drug, can help preserve vision in people with retinitis pigmentosa or a related condition called EMAP. Thirty participants will receive three injections into the eye over four months. The main goal is to see if the t…
Phase 1/2 • Sponsor: Centro de Pesquisa Rubens Siqueira • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could an antioxidant help treat chronic fatigue? new trial tests NAC
Disease control OngoingThis Phase 2 trial tests whether N-Acetylcysteine (NAC), an antioxidant, can help people with ME/CFS (chronic fatigue syndrome). Researchers will give 95 participants different doses of NAC or a placebo for four weeks, then measure brain glutathione levels and markers of oxidativ…
Phase 2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could an HIV drug help treat rett syndrome?
Disease control By invitation onlyThis phase 2 trial tests whether lamivudine, an antiviral drug, can improve symptoms in people with Rett syndrome, a rare genetic disorder that affects movement, communication, and behavior. Ten participants will take the drug by mouth for a set period, and researchers will measu…
Phase 2 • Sponsor: Maria Denise Fernandes Carvalho de Andrade • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Gene therapy trial aims to tame seizures in kids with rare epilepsy
Disease control OngoingThis early-stage study tests a gene therapy called ETX101 in 5 children with Dravet syndrome, a severe form of epilepsy. The therapy delivers a gene that helps calm overactive brain cells. Researchers will check if it safely reduces seizure frequency and improves thinking and dai…
Phase 1/2 • Sponsor: Encoded Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
CBD epilepsy drug under Real-World watch for rare seizure disorders
Disease control OngoingThis study follows about 111 people with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex who are taking Epidyolex (a CBD oral solution) for seizures. Researchers track how many stay on the drug for a year and how many seizure-free days they have. It's an o…
Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Bionic eye implant aims to bring back sight in advanced macular degeneration
Disease control OngoingThis study tests a device called the PRIMA System, which includes an implant placed under the retina and a special visual processor worn by the patient. The goal is to help people with advanced dry age-related macular degeneration (geographic atrophy) regain some central vision. …
Sponsor: Science Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Gene therapy after stem cell transplant shows promise for rare brain disease
Disease control OngoingThis study tests a one-time gene therapy infusion (FBX-101) given after a standard stem cell transplant in 6 children with infantile Krabbe disease, a severe genetic disorder affecting the nervous system. The therapy uses a harmless virus to deliver a working copy of the GALC gen…
Phase 1/2 • Sponsor: Forge Biologics, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for SMA patients in major trial
Disease control OngoingThis study tests whether adding taldefgrobep alfa to standard SMA treatments can improve muscle function in people with spinal muscular atrophy (SMA). About 269 participants, both walkers and non-walkers, will receive either the drug or a placebo for 48 weeks. The main goal is to…
Phase 3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental eye drug shows promise for rare Blindness-Causing disease
Disease control OngoingThis study tests an experimental drug called VP-001 for people with a rare genetic eye disease that causes vision loss. The drug is injected into the eye and aims to slow or stop further damage. Researchers will check safety and measure any changes in eyesight over about two year…
Phase 1/2 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gene therapy breakthrough? new trial targets duchenne muscular dystrophy
Disease control OngoingThis Phase 3 trial tests a gene therapy called SRP-9001 for Duchenne muscular dystrophy (DMD), a severe muscle-wasting disease. It includes 148 males who can and cannot walk. Participants receive a one-time IV infusion of the therapy or a placebo, and are followed for about 128 w…
Phase 3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo aims to tame Cushing's disease with fewer side effects
Disease control By invitation onlyThis study tests whether adding cabergoline to osilodrostat works better than osilodrostat alone for controlling Cushing's disease. About 50 adults with active Cushing's disease will receive either the combination or the single drug. The goal is to see if the combo can lower cort…
Phase 4 • Sponsor: University of Basrah • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Gene therapy shot could end monthly eye injections for wet AMD
Disease control OngoingThis Phase 3 trial tests a single injection of Ixo-vec gene therapy in 311 people with wet age-related macular degeneration (AMD). The goal is to see if it can maintain or improve vision as well as standard aflibercept injections, but with fewer follow-up treatments. Participants…
Phase 3 • Sponsor: Adverum Biotechnologies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Higher dose of spinraza tested in SMA patients who already tried risdiplam
Disease control OngoingThis study tests a higher dose of nusinersen (Spinraza) in 45 teenagers and adults with spinal muscular atrophy (SMA) who cannot walk and have already taken risdiplam. Participants receive two 50 mg loading doses two weeks apart, then 28 mg every four months for about two years, …
Phase 3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New pill aims to slow Parkinson's in patients with genetic mutation
Disease control OngoingThis study tests an experimental drug called BIA 28-6156 in people with Parkinson's disease who have a specific change in the GBA1 gene. The goal is to see if the drug can delay the worsening of movement-related daily living skills over 78 weeks. About 237 participants will recei…
Phase 2 • Sponsor: Bial R&D Investments, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could your own cells fight parkinson? new brain implant trial begins
Disease control By invitation onlyThis early-stage trial tests whether implanting a person's own lab-grown dopamine cells into their brain is safe for Parkinson disease. Nine participants aged 40-75 with Parkinson for at least 4 years will receive the injection. The goal is to see if the cells can replace lost do…
Phase 1 • Sponsor: Aspen Neuroscience • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a single gene injection slow frontotemporal dementia?
Disease control OngoingThis early-stage trial tests a gene therapy called PBFT02 for frontotemporal dementia (FTD) in people with specific genetic mutations. The therapy delivers a working copy of the GRN gene directly into the brain. The study involves 30 adults and primarily checks for safety and sid…
Phase 1/2 • Sponsor: Passage Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
One-Time eye injection could slow blindness in retinitis pigmentosa
Disease control OngoingThis study tests a gene therapy called SPVN06 for retinitis pigmentosa, an inherited eye disease that causes gradual vision loss. The treatment is given as a single injection under the retina. The trial includes 33 adults with advanced disease and will check safety and whether it…
Phase 1/2 • Sponsor: SparingVision • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New eye injection aims to stop vision loss in dry AMD patients
Disease control OngoingThis study tests whether monthly eye injections of ANX007 can prevent significant vision loss in people with dry age-related macular degeneration (AMD) that has progressed to geographic atrophy. About 659 participants will receive either the drug or a sham injection. The main goa…
Phase 3 • Sponsor: Annexon, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pill aims to tame Huntington's disease by targeting toxic proteins
Disease control OngoingThis study tests an oral drug called SKY-0515 in 120 adults with Huntington's disease. The goal is to see if it can lower harmful proteins in the blood, slow brain changes, and improve symptoms. Participants must be 25 or older with a confirmed genetic diagnosis and a certain lev…
Phase 2/3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a Nurse-Led program transform Women's health in hong kong?
Disease control OngoingThis trial tests a nurse-led health program for women aged 45 to 64 in Hong Kong. The program uses a 5-step approach (ask, advice, assess, assist, arrange) to help women manage conditions like high blood pressure, anxiety, and menopause symptoms. Researchers will compare the prog…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New Parkinson's pump shows promise in Real-World test
Disease control OngoingThis study follows about 427 adults with advanced Parkinson's disease who are receiving ABBV-951, a continuous infusion under the skin. Researchers want to see how well it controls symptoms like tremors and stiffness over three years in everyday medical practice. Participants att…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for wet AMD: two novel drugs enter final testing phase
Disease control OngoingThis Phase 3 study tests two new drugs, tarcocimab tedromer and tabirafusp tedromer, against the standard treatment aflibercept for wet age-related macular degeneration (AMD). The trial involves 675 participants who have not been treated before. The goal is to see if the new drug…
Phase 3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Gene therapy could end frequent eye injections for wet AMD
Disease control OngoingThis study tests a one-time gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. The treatment aims to help the eye produce its own medicine to stop leaky blood vessels, potentially replacing the need for repeated eye injecti…
Phase 2/3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could a headset tame inflammation in duchenne muscular dystrophy?
Disease control By invitation onlyThis pilot study tests a device called Travagus One, which stimulates a nerve in the ear to reduce inflammation in boys with Duchenne muscular dystrophy (DMD). Twenty boys aged 5-17 will use the headset at home for 5 minutes twice a day for one week. Researchers will measure infl…
Sponsor: taVNS AB • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study tracks bone safety of DMD drug vamorolone over years
Disease control OngoingThis study follows about 80 boys with Duchenne muscular dystrophy who have already taken vamorolone in earlier studies. Researchers want to see how safe the drug is over a longer time, especially its effect on bone health, like spine fractures. The boys continue taking vamorolone…
Phase 4 • Sponsor: Santhera Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New gel pump for Parkinson's: Real-World results under scrutiny
Disease control OngoingThis study follows about 300 adults with advanced Parkinson's who are already using Lecigon, a gel given through a pump to control movement problems. Researchers will track how well it works and what side effects occur over up to two years in everyday medical care. The goal is to…
Sponsor: Britannia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New syringe design tested for common eye disease treatment
Disease control OngoingThis study tests whether a pre-filled syringe is as safe as the traditional vial when giving the medicine bevacizumab for certain eye diseases. About 120 people with wet age-related macular degeneration, diabetic macular edema, or branch retinal vein occlusion will receive inject…
Phase 3 • Sponsor: Outlook Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cancer drug shows promise for rare blood vessel disorders in kids and young adults
Disease control OngoingThis study tests the drug alpelisib, already approved for some breast cancers, in people aged 2 months to 30 years with certain blood vessel growth disorders caused by PIK3CA or TIE2 gene changes. Participants take the drug for 2-3 years and attend up to 16 clinic visits to check…
Phase 2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for rare epilepsy: fenfluramine made available for dravet patients
Disease control ApprovedThis study offers fenfluramine to people with Dravet syndrome whose seizures have not improved with other medications. The goal is to provide access to the drug and monitor its safety. Participants must have a genetic diagnosis of Dravet syndrome and have tried all available seiz…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Phone support aims to improve mental health care in primary clinics
Disease control OngoingThis study tests a phone-based care management program for adults with depression, anxiety, or risky drinking. Participants get regular check-ins and support from a mental health technician, while their primary care doctor receives treatment recommendations. The goal is to see if…
Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Brain pacemaker shows promise for rare childhood epilepsy
Disease control OngoingThis pilot study tests whether deep brain stimulation (DBS) of specific brain pathways can safely reduce seizures in people with Lennox-Gastaut syndrome, a severe form of epilepsy. Five participants receive the electrical stimulation as an add-on to their usual treatment. The goa…
Sponsor: Liankun_Ren • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Last chance access: vatiquinone for mitochondrial disease patients
Disease control Expanded access (ended)This program offered vatiquinone, an experimental liquid medication, to patients with inherited mitochondrial diseases like Leigh syndrome who had already completed a previous safety study. The goal was to continue treatment for those who might benefit, but enrollment is now clos…
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Experimental drug hopes to slow rare muscle disease in two patients
Disease control By invitation onlyThis early-stage trial tests a daily injection of ASA-001 in two adults with a rare genetic muscle disease (ADSS1 deficient myopathy). The main goals are to see if the drug is safe and if it can slow the disease. Participants will take the drug for 8 months and have clinic visits…
Phase 1 • Sponsor: Cure ADSSL1 • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could vitamin B3 save sight in rare optic nerve disease?
Disease control OngoingThis study tests whether high-dose nicotinamide (vitamin B3) is safe and can help people with dominant optic atrophy, a rare genetic disease that slowly damages the optic nerve and causes vision loss. Researchers will give 25 adults 3 grams of nicotinamide daily and monitor for s…
Phase 2/3 • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can 'Zombie Cell' cleaners fight Alzheimer's? new trial tests idea
Disease control OngoingThis phase 2 trial is testing whether a combination of two drugs, dasatinib and quercetin, is safe and feasible for people with early-stage Alzheimer's or mild cognitive impairment. The drugs aim to clear aging 'senescent' cells that may contribute to brain damage. 48 participant…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can a shot stop ALS before it starts? new trial tests tofersen in gene carriers
Disease control OngoingThis phase 3 trial tests whether the drug tofersen can delay or prevent ALS in adults who carry a SOD1 gene mutation but have no symptoms yet. About 158 participants will receive either tofersen or a placebo, and researchers will track how many develop ALS within two years. The g…
Phase 3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Nasal gene therapy offers new hope for brain injury patients
Disease control By invitation onlyThis study follows 25 people aged 2 to 65 with cerebral palsy or brain damage from lack of oxygen who have already received a new gene therapy given as a nose spray. The therapy delivers 15 genes meant to repair the brain, reduce inflammation, and improve movement and thinking. R…
Sponsor: Healing Hope International • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Painless eye drops could save sight in kids with brain tumors
Disease control OngoingThis study tests a new painless nerve growth factor eye drop (CHF6467) in 36 children and young adults with optic pathway glioma, a brain tumor that often causes vision loss. The goal is to see if the drops can protect or improve vision without the pain side effects of standard n…
Phase 2 • Sponsor: Benedetto Falsini • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can stem cells restore hearing? early trial aims to find out
Disease control By invitation onlyThis early-phase study is testing whether stem cell therapies and experimental drugs can help repair inner ear damage in people with hearing loss or tinnitus. Researchers will monitor 120 adults over time using hearing tests and symptom surveys. The goal is to see if these regene…
Early phase 1 • Sponsor: Truway Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for rare eye disease: drug trial targets vision loss
Disease control OngoingThis study tests a drug called tinlarebant in 60 people with Stargardt disease, a genetic condition that causes vision loss. The goal is to see if the drug can slow damage to the retina and preserve eyesight. Participants take the drug or a placebo, and researchers measure change…
Phase 2/3 • Sponsor: Belite Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Parkinson's muscle supplement study pulled before it began
Disease control CancelledThis study aimed to see if a special nutritional supplement (AMS2434) could help people with Parkinson's disease build stronger muscles and improve brain function. It was designed for adults aged 55 and older with mild to moderate Parkinson's. However, the study was withdrawn bef…
Phase 1 • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can smarter hearing aids keep aging brains sharp?
Disease control OngoingThis study tests whether a personalized, data-driven hearing rehabilitation program can improve hearing, thinking, and quality of life in older adults with mild to moderate hearing loss. Two hundred first-time hearing aid users will be randomly assigned to either the new personal…
Sponsor: Kuopio University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can mindfulness beat OCD? large trial aims to find out
Disease control OngoingThis study tests whether mindfulness-based therapy can help people with obsessive-compulsive disorder (OCD). Researchers will compare mindfulness to standard cognitive behavioural therapy (CBT) in 420 adults with OCD. The goal is to see if mindfulness reduces OCD symptoms and to …
Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
One-Time gene therapy aims to halt rare muscle disease
Disease control OngoingThis study tests a single dose of SRP-9003 gene therapy in 17 people with limb girdle muscular dystrophy 2E/R4, a genetic muscle-weakening disease. The goal is to restore a missing protein in muscle cells and improve muscle function. Both walkers and non-walkers can join, and the…
Phase 3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Glasses that 'Talk' to Gene-Edited eyes: a new hope for blindness?
Disease control OngoingThis early-stage trial tests a combination treatment for retinitis pigmentosa, a genetic disease that causes blindness. Ten adults receive a single injection of GS030 gene therapy into one eye, then use special glasses that send light signals to the treated retina. The main goal …
Phase 1/2 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for rare tumors: drug may slow cancer growth
Disease control OngoingThis study tests a drug called lanreotide in 10 people with advanced or metastatic paraganglioma or pheochromocytoma, rare tumors that release hormones. The goal is to see if lanreotide can slow tumor growth compared to before treatment. Participants receive injections every 4 we…
Phase 2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Gene therapy shot could end monthly eye injections for wet AMD
Disease control OngoingThis study tests a gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. The treatment is given as one or two injections into the eye and aims to produce proteins that block abnormal blood vessel growth, potentially replacing …
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Higher dose of muscular dystrophy drug shows promise in new trial
Disease control OngoingThis Phase 3 trial tests whether higher doses of eteplirsen (Exondys 51) can safely improve muscle function in boys with Duchenne muscular dystrophy whose genetic mutation allows exon 51 skipping. About 160 ambulatory boys will receive one of three doses (30, 100, or 200 mg/kg) t…
Phase 3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Real-World study tests new Parkinson's pump treatment
Disease control OngoingThis study looks at how well a drug called foslevodopa-foscarbidopa works for people with advanced Parkinson's disease in France. About 250 adults whose doctors have already prescribed this drug will be followed for up to 12 months. The goal is to see if the treatment improves th…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could keytruda tame tough prostate cancers?
Disease control OngoingThis phase 2 study tests pembrolizumab (Keytruda) in 40 men with metastatic castration-resistant prostate cancer that has specific genetic flaws (mismatch repair deficiency or CDK12 inactivation). The goal is to see if the drug can shrink tumors or slow the cancer. Researchers wi…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Cool roofs may cool minds: trial targets Heat-Driven anxiety
Disease control OngoingThis study tests whether painting roofs with a special reflective coating can lower indoor temperatures and improve mental health. About 800 people in Ahmedabad, India, who live in homes with poor insulation will be randomly assigned to get a cool roof or not. Researchers will me…
Sponsor: Aditi Bunker • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can a lower dose of avastin save sight in preemies?
Disease control OngoingThis study tests whether lower doses of the drug bevacizumab (Avastin) can effectively treat a severe form of retinopathy of prematurity (ROP) in premature infants. The trial includes 77 babies with type 1 ROP in zone I, the most dangerous type. Each infant receives a single inje…
Phase 2 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Cancer-Killing virus combined with immunotherapy shows promise in advanced tumors
Disease control OngoingThis Phase 2 trial tests a genetically modified herpes virus (RP1) alone or with the immunotherapy drug nivolumab in people with advanced solid tumors, including melanoma, non-small cell lung cancer, and certain skin cancers. The study aims to see if the combination is safe and c…
Phase 2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Radioactive drug lutathera tested in teens with rare cancers
Disease control OngoingThis study is testing a radioactive drug called Lutathera in teenagers aged 12 to 17 who have rare tumors of the digestive system or adrenal glands. The goal is to see if the drug is safe and how much radiation reaches organs. Eleven teens are taking part, and researchers are wat…
Phase 2 • Sponsor: Advanced Accelerator Applications • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New pill targets aggressive tumors with genetic flaw
Disease control OngoingThis early-phase study tests an experimental oral drug (GSK4418959) in adults with advanced solid tumors that have specific genetic changes (dMMR or MSI-H). The drug works by blocking a protein (WRN) that these tumors need to survive. The study aims to see if the drug, alone or w…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for kids with hard-to-treat genetic seizures
Disease control OngoingThis study tests a new medicine called PRAX-562 in 77 children with rare genetic epilepsies (SCN2A or SCN8A). The goal is to see if it safely reduces motor seizures. The trial has two parts: a double-blind phase where some children get the drug and some get a placebo, followed by…
Phase 2/3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a pill save your sight? new trial targets blinding eye disease
Disease control OngoingThis Phase 3 trial tests whether a daily pill called tinlarebant can slow the growth of geographic atrophy, an advanced form of age-related macular degeneration that causes blind spots. About 429 adults with the condition will receive either the drug or a placebo for up to 2 year…
Phase 3 • Sponsor: Belite Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
One-Time gene injection aims to slow rare fatal brain disease in kids
Disease control OngoingThis early-stage study tests a one-time gene therapy injection into the spinal fluid of children aged 1-18 with CLN7 Batten disease, a rare and fatal genetic brain disorder. The main goal is to check safety, but researchers will also measure changes in movement, thinking, and vis…
Phase 1 • Sponsor: Benjamin Greenberg • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Stem cells injected into brain to fight Parkinson's
Disease control OngoingThis first-in-human trial tests a stem cell therapy called STEM-PD for Parkinson's disease. Eight participants with moderate Parkinson's will have dopamine-producing cells transplanted into a brain region affected by the disease. The main goal is to check safety over 12 months, w…
Phase 1 • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
OCD brain stimulation study pulled before it even started
Disease control CancelledThis study aimed to improve how deep brain stimulation (DBS) is targeted for people with severe obsessive-compulsive disorder (OCD). It planned to use brain scans to personalize the placement of electrodes. However, the trial was withdrawn before enrolling any participants, so no…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could wet AMD patients get fewer eye shots? new study tests early treatment breaks
Disease control OngoingThis study compares two drugs, aflibercept and brolucizumab, for wet age-related macular degeneration (AMD). Instead of the usual three monthly loading doses, it tests starting with longer intervals between injections right away. The goal is to see if this approach works just as …
Sponsor: Berner Augenklinik • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could peeling an extra layer during eye surgery prevent repeat detachment?
Disease control OngoingThis study compares two types of surgery for people with a detached retina. One group gets standard repair surgery, the other gets an extra step where a thin membrane is peeled away. Researchers want to see if this extra step lowers the chance of re-detachment and improves vision…
Sponsor: Berner Augenklinik • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
SPINRAZA study tracks movement in adults with spinal muscular atrophy
Disease control OngoingThis study follows 20 adults with spinal muscular atrophy (SMA) type II who are already taking SPINRAZA. Researchers will measure motor function using a 32-point scale over 27 months to see if the drug helps maintain or improve movement. The goal is to better understand how SPINR…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Parkinson's vaccine trial aims to slow disease progression
Disease control OngoingThis study tests a vaccine called ACI-7104.056 in 150 people with early-stage Parkinson's disease. The goal is to see if it is safe and helps the body fight a protein linked to Parkinson's. Participants must already be on stable low-dose levodopa. This is not a cure, but may help…
Phase 2 • Sponsor: AC Immune SA • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Gene therapy boost for krabbe patients after transplant
Disease control OngoingThis early-phase trial tests a single infusion of a gene therapy called FBX-101 in 9 people with Krabbe disease who have already received a stem cell transplant. The therapy uses a harmless virus to deliver a working copy of the GALC gene, aiming to improve motor function and saf…
Phase 1/2 • Sponsor: Forge Biologics, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Avastin vs eylea: which eye drug needs fewer shots?
Disease control OngoingThis study compares two drugs, Avastin and Eylea, given as eye injections for wet age-related macular degeneration (AMD). The main goal is to see which drug requires fewer injections over two years while still controlling the disease. Researchers will also check vision, eye thick…
Phase 2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Gene therapy breakthrough offers hope for rare brain disease
Disease control By invitation onlyThis study tests a single dose of AVASPA gene therapy given directly into the brain of children with Canavan disease, a rare and severe genetic disorder that damages white matter. The therapy aims to restore a missing enzyme to help the brain produce myelin and slow disease progr…
Phase 1/2 • Sponsor: Myrtelle Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for duchenne kids: drug combo after gene therapy tested
Disease control OngoingThis study tests an experimental drug called EDG-5506 (sevasemten) in 43 children and teens aged 6 to 17 with Duchenne muscular dystrophy who have already received gene therapy. The goal is to see if the drug is safe and how it affects muscle damage markers. Participants are rand…
Phase 2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Hope for duchenne: new cell therapy shows promise in Long-Term trial
Disease control OngoingThis study tests the long-term safety and effectiveness of a cell therapy called deramiocel (CAP-1002) in people with Duchenne muscular dystrophy who completed the earlier HOPE-2 trial. Participants receive an infusion of deramiocel every 3 months for about 5 years, with the opti…
Phase 2 • Sponsor: Capricor Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can a One-Stop clinic solve the mystery of functional disorders?
Diagnosis OngoingFunctional somatic disorders cause persistent physical symptoms that doctors cannot explain by other diseases. The DISTRESS trial evaluates a new clinic where internal medicine doctors, trained to recognize these disorders, examine patients and provide guidance to their general p…
Sponsor: Regionshospitalet Silkeborg • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Rotation chairs face off: can a newer device match the gold standard for vertigo diagnosis?
Diagnosis By invitation onlyThis study tests whether two mechanical rotation chairs—the TRV and the newer Rotundum—are equally accurate at diagnosing benign paroxysmal positional vertigo (BPPV), a common cause of brief dizzy spells triggered by head movements. About 200 adults with typical BPPV symptoms wil…
Sponsor: Aalborg University Hospital • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
AI reads brain scans to spot Parkinson's lookalikes
Diagnosis OngoingThis study tests an AI tool called AIDP that analyzes MRI scans to help diagnose Parkinson's disease and two similar conditions (MSA and PSP). Researchers at 21 sites will compare the AI's diagnosis to that of movement disorder specialists. The goal is to see if the tool can impr…
Sponsor: University of Florida • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
New scan could replace invasive test for Cushing's disease diagnosis
Diagnosis By invitation onlyThis study compares a new, non-invasive PET-MRI scan to the standard invasive test (IPSS) for finding pituitary tumors in people with Cushing's disease. About 43 adults with confirmed Cushing's will get both tests to see which is more accurate. The goal is to make diagnosis safer…
Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
AI eye on brain bulges: software aims to spot hidden aneurysms
Diagnosis OngoingThis study evaluates RDX-Aneurysm, a computer-assisted detection software designed to help radiologists find saccular intracranial aneurysms (bulging blood vessels in the brain) on MRI scans. Researchers will analyze 550 past scans—half with confirmed aneurysms and half without—t…
Sponsor: Taipei Medical University Shuang Ho Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Spit test could spot ALS early
Diagnosis OngoingThis study is testing whether a simple saliva sample can help diagnose amyotrophic lateral sclerosis (ALS). Researchers will analyze RNA in the saliva of 653 people, including ALS patients and healthy volunteers. If the test works, it could offer a faster, less invasive way to di…
Sponsor: ZIWIG • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Needle-Free carpal tunnel diagnosis on the horizon?
Diagnosis By invitation onlyThis study explores whether ultrasound elastography, a non-invasive imaging technique, can accurately diagnose carpal tunnel syndrome (CTS) without the need for painful needle-based nerve tests. Researchers will enroll 80 participants—some with CTS and some healthy volunteers—to …
Sponsor: Da Nang Family General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:04 UTC
-
Simple blood test could catch hidden heart disease in seniors
Diagnosis By invitation onlyThis study is testing a way to find cardiac amyloidosis—a rare but serious heart condition—earlier in people aged 65 and older. Researchers in Turkey will screen 800 patients at family medicine clinics using simple blood tests and medical history. The goal is to see if this appro…
Sponsor: Kotyora Family Medicine Health Management and Education Association • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Eye-Tracking tech could spot macular degeneration faster
Diagnosis OngoingThis study tests a device called AVIGA that tracks eye movements to detect vision problems in people with wet age-related macular degeneration (AMD). Researchers will compare the device's results with standard eye exams to see if it can reliably spot disease activity. The goal is…
Sponsor: Tan Tock Seng Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Saliva test could replace complex procedures for Cushing's diagnosis
Diagnosis OngoingThis study aims to see if a simple, inexpensive saliva test can accurately diagnose Cushing's syndrome, a condition where the body makes too much cortisol. Researchers will compare two automated saliva test methods in 380 adults who are already being checked for the condition. Th…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
New test could predict falls in muscle disease patients
Diagnosis By invitation onlyThis study aims to create a simple test battery to determine fall risk in people with neuromuscular disorders, such as muscular dystrophy or ALS. Researchers will assess 108 participants using several physical tests like walking, standing, and rising from a chair. The goal is to …
Sponsor: LMU Klinikum • Aim: Diagnosis
Last updated Jun 26, 2026 16:30 UTC
-
Could 10 minutes of daily mindfulness shield children from anxiety?
Prevention OngoingThis trial tests whether 5-10 minutes of daily mindfulness and compassion training in school can prevent anxiety and depression in children aged 6-16. About 1,750 pupils will take part, with some classes doing the training for 10 weeks and others not. Researchers will track menta…
Sponsor: Lund University • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
Brain health boost: yoga, music, and diet may ward off neurological disorders
Prevention OngoingThis trial tests whether a combination of lifestyle interventions—brain training, yoga, music therapy, and a special diet—can slow or reverse early signs of neurological disorders like dementia, stroke, epilepsy, and Parkinson's disease. Participants are healthy adults aged 50 an…
Sponsor: Vineet Punia MD • Aim: Prevention
Last updated Jul 12, 2026 00:00 UTC
-
Happy older latinos are active: a walk a day may keep the blues away
Prevention OngoingThis study tests whether a health promotion program can prevent anxiety and depression in older Latino adults who are at risk. 240 participants will either join a program with group walks and social sessions led by a community health worker, or attend a healthy lifestyles educati…
Sponsor: University of Miami • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Eye surgery trial to prevent blindness in stickler syndrome pulled before start
Prevention CancelledThis study aimed to see if a surgical procedure called scleral buckling could prevent retinal detachment in people with Stickler syndrome, a genetic condition that raises the risk of vision loss. The plan was to treat one eye in patients aged 5 to 35 who had already lost vision i…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Could a simple drug stop deadly organ failure after surgery?
Prevention OngoingThis study tests if a drug called dalargin can prevent serious organ problems like kidney injury, lung failure, or heart damage after major abdominal surgery. About 200 adults having high-risk surgery will get either dalargin or a placebo for 3 days. The goal is to see if dalargi…
Phase 3 • Sponsor: Botkin Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Can a video-based therapy tame tough behaviors in kids with rare genetic disorders?
Symptom relief OngoingThis study tests a virtual behavioral therapy (Functional Behavioral Training) for children aged 2-12 with genetic syndromes like Fragile X, Angelman, or Rett syndrome who have challenging behaviors. The therapy teaches parents how to identify what triggers problem behaviors and …
Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Giving Parkinson's patients a say may boost their Brain's ability to learn movement
Symptom relief OngoingPeople with Parkinson's disease often struggle with motivation and motor learning, which can limit rehabilitation. This trial compares two ways of practicing a joystick task: one group chooses the stories and exercises they practice, while the other follows the same routine witho…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a personalized mix of nerve stimulation and therapy rewire the brain for better mental health?
Symptom relief OngoingResearchers are testing a personalized, non-drug treatment for adults with ongoing depression, anxiety, trauma-related symptoms, sleep problems, attention difficulties, or substance-use concerns. Instead of assigning treatment by diagnosis alone, the study selects approaches base…
Sponsor: Tactical Mind Research Coalition, Inc. • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could a new cycling style help MS patients walk better and feel less tired?
Symptom relief OngoingThis study tests a new type of cycling called eccentric cycling for people with multiple sclerosis. Researchers want to see if it improves muscle strength, walking ability, fatigue, and quality of life better than standard cycling. Sixty adults with MS who can walk independently …
Sponsor: University of Liege • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Vibrating wristband put to the test for Parkinson's relief
Symptom relief OngoingResearchers are exploring whether a wrist-worn device called the Beechband, which delivers intermittent vibrations, can change movement symptoms and everyday experiences for people with Parkinson's disease. About 60 participants will be randomly assigned to wear the device for ei…
Sponsor: University of Exeter • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Eye workouts may steady Parkinson's patients
Symptom relief By invitation onlyThis study tests whether a program of supervised eye exercises can improve physical function, balance, and reduce fear of falling in people with Parkinson's disease. 34 participants will do progressive eye movements and gaze stabilization exercises in a clinic setting. The goal i…
Sponsor: Pardis Specialized Wellness Institute • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New VR device aims to make exercise fun for kids with muscle weakness
Symptom relief OngoingThis early study tests a virtual reality rehabilitation device for children with spinal muscular atrophy (SMA), a genetic condition that causes progressive muscle weakness. The device uses games, muscle sensors, and a grip-strength ball to make home exercises more engaging. Resea…
Sponsor: University of Oxford • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can yoga calm anxious minds and sharpen focus?
Symptom relief By invitation onlyResearchers at the University of Illinois at Chicago are studying which parts of a yoga practice affect anxiety, mood, and thinking in highly anxious college women. About 60 participants complete four sessions that include yoga postures, breathwork, meditation, or watching a yoga…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
New hope for Parkinson's pain: drug trial targets tough-to-treat discomfort
Symptom relief OngoingThis study tests whether a drug called crisugabalin can safely reduce pain in people with Parkinson's disease who have a type of pain called nociplastic pain. About 166 adults will take either the drug or a placebo twice a day for 12 weeks. Researchers will measure pain levels an…
Phase 4 • Sponsor: Guangdong Provincial People's Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Could a liver drug help people see color? tiny trial launched
Symptom relief PausedThis early-phase trial tests whether an FDA-approved drug called glycerol phenylbutyrate (PBA) can improve vision in people with a rare form of color blindness caused by mutations in the ATF6 gene. Only 2 participants are enrolled, and they will take PBA three times daily while t…
Early phase 1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Tailored therapy for kids with OCD: a new hope?
Symptom relief OngoingThis study at Johns Hopkins tests whether using personalized mobile health assessments can improve cognitive-behavioral therapy (CBT) for children aged 8-17 with obsessive-compulsive disorder (OCD). 30 participants will receive either standard CBT or CBT guided by their own sympt…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
App plus therapist sessions may help WTC responders with PTSD
Symptom relief By invitation onlyThis study tests whether a mobile app called PTSD Coach, with or without brief clinician support, can reduce PTSD, anxiety, depression, and sleep problems in World Trade Center responders living in Florida. About 120 English- or Spanish-speaking responders will be randomly assign…
Sponsor: Florida International University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a phone app and a health worker ease depression in rural HIV care?
Symptom relief OngoingResearchers are adapting a mobile health program that pairs the PositiveLinks app with video counseling from a community health worker. The study enrolls 60 people in Florida who have HIV and mild to moderate anxiety or depression. Participants receive either the enhanced counsel…
Sponsor: University of Florida • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can learning positive emotions stop burnout for violence prevention staff?
Symptom relief OngoingThis study tests a program called FOREST that teaches positive emotion skills to staff working in gun violence prevention. The goal is to reduce burnout, anxiety, and depression, and improve well-being and job retention. One hundred employees from UCAN in Chicago will take part o…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can VR and a tiny ear ZAP ease shoulder pain and anxiety?
Symptom relief CancelledThis study combines virtual reality with a gentle electrical pulse on the ear (called taVNS) to help people with chronic shoulder pain who are waiting for surgery. The goal is to see if this drug-free approach can reduce pain, anxiety, and depression. Only 10 people will take par…
Sponsor: East Kent Hospitals University NHS Foundation Trust • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a home Brain-Training program ease Parkinson's memory woes?
Symptom relief OngoingThis pilot study tests whether a home-based program called HOBSCOTCH, originally designed for epilepsy, can be adapted for people with Parkinson's disease. Ten participants will work one-on-one with a coach in nine virtual sessions to learn problem-solving strategies and memory a…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can hula dancing ease Parkinson's symptoms?
Symptom relief By invitation onlyResearchers at the University of Hawaii are studying whether a weekly hula class can improve quality of life, well-being, balance, and motor symptoms in people with Parkinson's disease. The trial enrolls 40 adults with idiopathic Parkinson's disease who can attend in-person sessi…
Sponsor: University of Hawaii • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a daily pill quiet the spinning of vertigo?
Symptom relief CancelledResearchers are testing an experimental oral tablet called APSLXR in people with Meniere's disease or vertigo of vestibular origin. The main goal is to check whether the drug is safe when taken once a day for 60 days. A small group will also have blood tests to see how the body p…
Phase 1 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can brain stimulation be tuned to improve sleep in Parkinson's?
Symptom relief OngoingThis trial tests whether adjusting deep brain stimulation (DBS) settings specifically for sleep can improve sleep quality in people with Parkinson's disease. Participants already use an adaptive DBS system that responds to brain signals. Researchers will compare three different s…
Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
AI-Powered online therapy aims to ease depression and anxiety
Symptom relief OngoingThis study tests whether an online problem-solving therapy, matched to a person's specific symptoms using machine learning, can reduce depression and anxiety better than usual care. About 380 adults with moderate symptoms will take part. The goal is to create a precise, scalable …
Sponsor: Wuhan Mental Health Centre • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Magic mushroom compound tested for OCD in early trial
Symptom relief OngoingThis early-phase study at Johns Hopkins University is testing whether psilocybin, the active compound in magic mushrooms, can safely help people with obsessive-compulsive disorder (OCD). Thirty-five adults with moderate to severe OCD who have already tried other treatments will r…
Early phase 1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a simple care program boost mood in epilepsy patients?
Symptom relief OngoingThis study tests whether a 24-week collaborative care program can improve quality of life for adults with epilepsy who also have anxiety or depression. The program includes regular check-in calls and expert recommendations from a psychiatrist and neurologist. Researchers will com…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Laughing gas takes on the needle: could a simple breath ease one of Medicine's most uncomfortable procedures?
Symptom relief OngoingThis study investigates whether breathing a 50:50 mix of nitrous oxide (laughing gas) and oxygen can reduce pain and anxiety during insertion of a central venous catheter, a common but uncomfortable procedure. Adults aged 18 to 65 who have never used nitrous oxide will be randoml…
Sponsor: Institute for Oncology and Radiology of Serbia • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can gentle touch therapy calm Parkinson's tremors?
Symptom relief By invitation onlyThis trial tests whether CranioSacral therapy, a gentle manual therapy applied to the feet, diaphragm, neck, and skull, can reduce tremors and improve movement precision in people with Parkinson's disease. Five participants will receive 90-minute sessions twice a month for three …
Sponsor: Zia, Al Raza • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Personalized brain maps could make Parkinson's stimulation more precise
Symptom relief By invitation onlyThis study tests whether using advanced brain imaging to guide deep brain stimulation (DBS) can better control tremor in people with Parkinson's disease while avoiding side effects like involuntary movements. Twenty adults who already have DBS implants will have their stimulation…
Sponsor: Duke University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Oxygen chamber treatment tested for long COVID fatigue relief
Symptom relief OngoingThis study is testing whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can improve symptoms like fatigue and brain fog in people with post-COVID syndrome. About 40 adults with long COVID will receive the treatment. The main goal is to see if a la…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Can online family therapy ease childhood anxiety and OCD?
Symptom relief OngoingThis study compares two low-intensity family treatments for children aged 7-13 with anxiety or obsessive-compulsive disorder (OCD): internet-delivered cognitive behavioral therapy (CBT) and a parent-led reading program. Both are delivered via telehealth and compared to a relaxati…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Spinal zaps and exercise may boost walking after injury
Symptom relief OngoingThis study tests whether combining motor skill training with a non-invasive spinal stimulation can improve walking, balance, and strength while reducing muscle spasticity in people with incomplete spinal cord injury. Twenty-eight participants will do a series of standing exercise…
Sponsor: Shepherd Center, Atlanta GA • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New coaching program aims to help young cancer survivors connect with friends
Symptom relief OngoingThis study tests a communication coaching program for adolescent and young adult cancer survivors (ages 18-35) who have finished treatment at least a year ago. Participants complete online sessions and AI coaching to improve how they talk with peers. The goal is to see if the pro…
Sponsor: Milton S. Hershey Medical Center • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Power training shows promise for Parkinson's slowness
Symptom relief OngoingThis study looked at whether a special exercise program focusing on muscle power (moving quickly) could help people with Parkinson's disease who have slow movements (bradykinesia). Twenty-two adults with Parkinson's were split into two groups: one did standard exercises, and the …
Sponsor: Federal University of Health Science of Porto Alegre • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Coloring and music may calm cancer screening fears
Symptom relief By invitation onlyThis trial tests whether a 20-minute session of mandala coloring while listening to slow instrumental music can reduce cancer fear and anxiety in women undergoing cancer screening. Women aged 30 to 65 attending a screening center will be randomly assigned to either the coloring a…
Sponsor: Agri Ibrahim Cecen University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Wearable patch promises stress relief without pills
Symptom relief OngoingThis study tests a topical patch called PEACE that uses gentle vibrations to help people feel less stressed or anxious. 150 adults aged 18 to 85 who have stress or anxiety will wear either the active patch or a sham (fake) patch for 14 days. Researchers will measure changes using…
Sponsor: SuperPatch Limited LLC • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
New study tests workplace coaching to keep Parkinson's patients on the job
Symptom relief OngoingThis study tests a personalized workplace intervention for 124 Dutch workers with Parkinson's disease, cerebellar ataxia, hereditary spastic paraparesis, or slowly progressive neuromuscular/mitochondrial disorders. A trained facilitator helps employees and their managers identify…
Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Nature as therapy? a new trial tests outdoor outings for anxious kids
Symptom relief CancelledThis trial tests whether spending time in nature can reduce anxiety in children aged 9-12 who have experienced adverse childhood events. Participants are assigned to either group nature outings, family outings, or a waitlist. The goal is to see if these nature-based activities im…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Rubber band trick may take the sting out of IV needles
Symptom relief By invitation onlyThis study tests whether using a hand extension rubber during IV insertion can reduce pain, anxiety, and improve satisfaction. Researchers will enroll 114 adults who need an IV and randomly assign them to use the rubber or not. The goal is to see if this simple, low-cost distract…
Sponsor: Necmettin Erbakan University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Faith-Based therapy aims to heal trauma in young women
Symptom relief OngoingThis trial tests a counseling program called Mpata Yathu ('Our Space') for adolescent girls and young women in Zambia who have experienced gender-based violence and may be living with or at risk for HIV. The program uses problem-solving therapy delivered by trained lay counselors…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Ear zaps may ease Parkinson's speech and movement woes
Symptom relief OngoingThis study tests whether mild electrical stimulation of the ear, combined with physical and speech therapy, can improve symptoms like voice problems, swallowing, and balance in people with Parkinson's disease. 46 participants will receive either active or sham stimulation during …
Sponsor: Universidade da Coruña • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can a meditation app fix sleep for blood cancer patients?
Symptom relief OngoingThis study looks at whether using the Calm meditation app for 10 minutes a day can help blood cancer patients who have trouble sleeping. Researchers will track sleep, mood, and inflammation in 276 participants over 20 weeks. The goal is to find a simple, drug-free way to improve …
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can online therapy or parent coaching ease childhood anxiety? a head-to-head trial aims to find out.
Symptom relief OngoingThis trial compares two forms of cognitive-behavioral therapy (CBT) for children and teens with anxiety or obsessive-compulsive disorder (OCD). One approach uses internet-delivered modules with therapist guidance; the other trains parents to lead exposure exercises with their chi…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Magic mushroom compound tested for stubborn OCD
Symptom relief OngoingThis small early-phase study is testing whether psilocybin, the active ingredient in magic mushrooms, combined with supportive therapy can safely help people with obsessive-compulsive disorder (OCD) that hasn't responded to standard treatments. Ten adults with treatment-resistant…
Phase 1 • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Can robot legs help Non-Walking kids join in at school?
Symptom relief By invitation onlyThis pilot study explores whether robot-assisted walking devices can be used in schools to help children who cannot walk independently. The devices attach to a walker and power leg movements, allowing children to stand and walk upright. The study aims to identify the best ways to…
Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Ultrasound-Guided injections may offer superior pain relief for common arm conditions
Symptom relief OngoingThis study compares three treatments for shoulder impingement and carpal tunnel syndrome: ultrasound-guided corticosteroid injections, standard injections guided by touch, and oral pain medication. Researchers want to see which approach provides the best long-term pain relief, im…
Phase 4 • Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Could a gentle zap to the scalp sharpen the Parkinson's brain?
Symptom relief OngoingThis study investigates whether a painless, low-intensity electrical current applied to the scalp can improve cognitive function — specifically the ability to stop an action when needed — in people with Parkinson's disease. The trial includes 50 Parkinson's patients and 40 health…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Could a simple drink ease Parkinson's constipation?
Symptom relief OngoingThis study tests a new functional drink made with chicory inulin, B-vitamins, and vitamin D to see if it can improve constipation and overall well-being in people with Parkinson's disease. About 56 participants will drink either the active supplement or a placebo twice daily for …
Sponsor: University of Ulster • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Online therapy could ease anxiety in autistic teens
Symptom relief OngoingThis study tests an internet-based cognitive behavioral therapy (CBT) program designed to help autistic adolescents aged 11-17 manage anxiety. The program, called LUNA-Adolescent, is parent-led and delivered online, making it easier for families who cannot access in-person therap…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Ancient chinese music tunes tested as depression treatment
Symptom relief By invitation onlyThis study tests whether a unique music therapy, based on Traditional Chinese Medicine's five-element theory, can help men with depression and anxiety when added to their usual medication. One hundred male inpatients will receive either standard drugs alone, drugs plus regular mu…
Sponsor: University of Malaya • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Cancer survivors find hope in Peer-Led Self-Management program
Symptom relief OngoingThis study tests a 7-session, peer-led self-management program for 234 cancer survivors who recently finished treatment with curative intent. The program aims to reduce anxiety and depression by teaching symptom management skills in a group setting. Participants are from central …
Sponsor: University of Aarhus • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
New CalmER therapy aims to lower anxiety in hospital staff
Symptom relief OngoingThis study tests whether a new therapy called Emotional Resolution (EmRes) can help reduce anxiety in healthcare workers. About 150 hospital workers with mild to moderate anxiety will either receive EmRes or a mindfulness-based gratitude exercise. The goal is to see if EmRes lead…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New speech therapy approach tested for kids with apraxia
Symptom relief OngoingThis study tests a speech therapy method called Rapid Syllable Transition (ReST) in children aged 5 to 8 with childhood apraxia of speech, a condition that makes it hard to say sounds correctly. The goal is to see if the therapy is practical and helps improve speech clarity and m…
Sponsor: Aline Mara de Oliveira • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Ultrasound-Delivered pain gel shows promise for carpal tunnel sufferers
Symptom relief OngoingThis study tests whether a pain-relief gel (pregabalin) delivered through the skin using ultrasound can reduce pain and improve hand function in people with carpal tunnel syndrome. The treatment is given four times a week for a month, and compared to standard ultrasound therapy w…
Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Can rewriting your life story improve mental health? small trial tests new therapy
Symptom relief OngoingThis study tests a therapy called RETELL that helps people with severe mental illness explore and reshape their life stories. The goal is to improve personal recovery, quality of life, and identity. Twenty adults with conditions like schizophrenia, bipolar disorder, or PTSD will …
Sponsor: University of Aarhus • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Parent training boosts speech therapy for kids with apraxia
Symptom relief OngoingThis study looks at whether training parents to help with speech therapy at home improves outcomes for children with childhood apraxia of speech (CAS). Forty children aged 2 to 7 will receive standard speech therapy twice a week for 8 weeks. Some parents will get direct coaching …
Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could two weeks of therapy beat six months for anxiety?
Symptom relief OngoingThis study tests whether a short, intensive course of cognitive behavioral therapy (CBT) over 2 weeks works better than the usual weekly sessions over 6 months for people with anxiety disorders. 120 adults with conditions like panic disorder, OCD, or PTSD will be randomly assigne…
Sponsor: Amsterdam UMC, location VUmc • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New pouch aims to make mealtimes safer for Huntington's patients
Symptom relief CancelledThis study was designed to test whether a reusable pouch called DoddleBags could help people with Huntington's disease eat more easily and safely. The pouch holds pureed food and can be used with an anti-choking cap or spoon attachment. The trial was withdrawn before any particip…
Sponsor: University of Hull • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
VR headsets aim to ease OCD brain treatment — but study pulled
Symptom relief CancelledThis study planned to see if using virtual reality (VR) before a brain stimulation treatment called TMS could help people with OCD feel more comfortable. It was designed for adults already approved for TMS. However, the study was withdrawn before any participants were enrolled, s…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Can a phone app and a coach help Spanish-Speaking patients beat depression?
Symptom relief By invitation onlyThis study tests a digital cognitive behavioral therapy program (SilverCloud) for Spanish-speaking adults with depression or anxiety. 426 participants will either use the program on their own or get extra support from a peer coach via phone or messaging. The goal is to see if add…
Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Pregnancy stress? a Step-Count program might help
Symptom relief By invitation onlyThis study tests whether a physical activity program can help pregnant people with symptoms of depression or anxiety feel better. 88 participants will be given a step goal and wear an activity tracker. The program includes weekly reminders and motivational coaching every two week…
Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Can a website beat the blues? new study tests online CBT for stressed students
Symptom relief OngoingThis study tests whether an internet-based self-help program called VIVIM can help university students with anxiety and depression. About 108 students will be randomly assigned to use VIVIM or receive usual support from their university counseling service. They will fill out ques…
Sponsor: University Rovira i Virgili • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New program aims to heal war trauma passed down in refugee families
Symptom relief OngoingThis study tests a program that combines family group sessions with a virtual peer mentoring program for US-born teens (ages 14-17) whose parents resettled as refugees. The goal is to reduce symptoms of PTSD, depression, anxiety, and behavior problems caused by intergenerational …
Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Home exercise program shows promise for rare movement disorder
Symptom relief By invitation onlyThis study tests whether a 12-week strength and functional exercise program, done at home via video calls with a physiotherapist, can improve walking, balance, and daily life in people with Hereditary Spastic Paraplegia (HSP). Twenty participants aged 16 to 70 will each experienc…
Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New group therapy aims to curb suicide risk in active duty troops
Symptom relief OngoingThis study tests a 12-session group therapy program (G-BCBT) for active duty military personnel who have recent suicidal thoughts or a recent suicide attempt. The therapy teaches emotion regulation, cognitive flexibility, and relapse prevention skills. Researchers will measure ch…
Sponsor: University of North Carolina, Charlotte • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Could a Head-Zap device ease Parkinson's at home?
Symptom relief By invitation onlyThis study tests whether a gentle electrical current applied to the back of the head (cerebellar tDCS) can improve both movement and mood in people with mild to moderate Parkinson's disease. Twenty-five participants will use a portable device at home for 8 days. Researchers will …
Sponsor: Université Libre de Bruxelles • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a simple muscle zap boost pain relief for back pain sufferers?
Symptom relief By invitation onlyThis study looks at whether adding a daily 30-minute muscle stimulation session can improve pain control and quality of life for people who already have a spinal cord stimulator (BurstDR) for chronic back pain. Sixty adults with failed back surgery syndrome or persistent spinal p…
Sponsor: Jessa Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Can learning about pain or using tape ease carpal tunnel symptoms?
Symptom relief OngoingThis study tests two simple treatments for mild to moderate carpal tunnel syndrome: pain neuroscience education (learning how the brain processes pain) and kinesio taping (applying elastic tape to the wrist). Sixty adults aged 18 to 60 with symptoms for at least 3 months will rec…
Sponsor: Middle East University • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
New gel could make eye injections Pain-Free
Symptom relief By invitation onlyThis study compares a new numbing gel (chloroprocaine HCl 3%) to standard eye drops plus a shot for pain relief during eye injections. About 236 adults with conditions like diabetic macular edema or age-related macular degeneration will take part. The goal is to see if the gel wo…
Phase 4 • Sponsor: Harrow Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Could a simple tourniquet change cut Post-Surgery pain and opioid use?
Symptom relief OngoingThis study tests whether using a lower-pressure tourniquet during orthopedic surgeries can reduce pain and the need for opioid painkillers afterward. Standard tourniquets use high pressure, which can cause muscle weakness and pain. The experimental device sets pressure based on t…
Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Brain training may boost hearing and thinking in older cochlear implant users
Symptom relief By invitation onlyThis study tests whether an 8-week auditory-cognitive training program can improve speech recognition and cognitive function in older adults (60+) who have had a cochlear implant for 3 months to 3 years. Participants will do computer-based listening and thinking exercises at home…
Sponsor: Gallaudet University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Parkinson's patients try lifestyle overhaul: stress, exercise, sleep, and diet targeted
Symptom relief OngoingThis study tests whether a personalized lifestyle program focusing on stress, exercise, nutrition, sleep, and self-management can improve quality of life for people with Parkinson's disease. 256 participants will be randomly assigned to either work on their goals independently or…
Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
CBD spray calms Alzheimer's anxiety? early trial hints at relief
Symptom relief OngoingThis small, early-stage study tested a high-CBD, low-THC liquid spray for 8 weeks in 12 older adults with mild cognitive impairment or mild-to-moderate Alzheimer's who also had significant anxiety or agitation. The goal was to see if the treatment could reduce these behavioral sy…
Early phase 1 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Home-Based balance training shows promise for MS and Parkinson's patients
Symptom relief OngoingThis study tests whether a 4-week telerehabilitation program can improve balance and quality of life in 36 people with multiple sclerosis or Parkinson's disease. Participants do balance exercises at home while monitored by a hospital physiotherapist. The results are compared to s…
Sponsor: IRCCS San Camillo, Venezia, Italy • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Carpal tunnel showdown: shots or knife?
Symptom relief OngoingThis study looks at two treatment plans for carpal tunnel syndrome, which causes hand numbness and pain. One plan starts with up to two steroid injections, then offers surgery if needed. The other plan goes straight to surgery. About 258 adults with mild to moderate symptoms will…
Phase 4 • Sponsor: Diakonhjemmet Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Mindfulness therapy tested to calm Parkinson's stress
Symptom relief OngoingThis study tests whether mindfulness-based cognitive therapy (MBCT) can reduce psychological distress in people with Parkinson's disease. 174 participants with mild-to-moderate stress symptoms will either receive MBCT or continue usual care. The main goal is to see if MBCT lowers…
Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Memory boot camp for Parkinson's: new study tests brain training
Symptom relief OngoingThis study tests two types of memory training in 120 people with Parkinson's disease and mild cognitive impairment. Participants complete 8 weekly sessions of either process or strategy training. The goal is to see if these exercises improve remembering to do tasks in daily life,…
Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Online support groups and telemedicine aim to ease Parkinson's and dementia burden
Symptom relief OngoingThis study looks at whether online community support and telemedicine can improve quality of life for people with Parkinson's disease, Lewy body dementia, and related conditions, as well as their caregivers. About 632 participants will receive palliative care training for their d…
Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Metaverse therapy: could virtual cooking and escape rooms heal the brain?
Symptom relief OngoingThis study tests a set of virtual reality exergames in the Metaverse to help people with neurological conditions like multiple sclerosis, Parkinson's disease, stroke, and traumatic brain injury improve their cognitive skills. 25 participants will try games like virtual cooking an…
Sponsor: Istituto per la Ricerca e l'Innovazione Biomedica • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Breathe away the pressure: biofeedback trial targets student dentist anxiety
Symptom relief By invitation onlyThis study tests whether a 5-week heart rate variability biofeedback program can lower stress and anxiety in 50 dentistry students moving from classroom to clinic. Participants in the training group practice slow breathing with real-time feedback, while a control group receives n…
Sponsor: Egas Moniz - Cooperativa de Ensino Superior, CRL • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Gaming therapy aims to reduce repetitive hand movements in rett syndrome
Symptom relief OngoingThis study tests whether personalized computer games can help people with Rett syndrome use their arms more purposefully and reduce repetitive hand movements. Fourteen participants will play games that reward them for separating their hands and reaching for targets. The training …
Sponsor: Georgetown University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could magnetic pulses lift depression in autism?
Symptom relief OngoingThis study tests whether a type of brain stimulation called rTMS can reduce depression in people with autism. Twenty-four participants aged 13 to 26 will receive either real or sham (fake) stimulation to see if it helps. The goal is to find a new way to treat depression that hasn…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can a computer program help calm anxiety in dementia?
Symptom relief OngoingThis study tests a special therapy program delivered over the internet for people with mild cognitive impairment or dementia who also feel anxious. The program uses cognitive behavioral therapy (CBT) techniques to help manage worry and fear. Researchers will measure changes in an…
Sponsor: The University of Queensland • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Walking while counting: new training may boost brain and body in DMD boys
Symptom relief By invitation onlyThis study tests whether a dual-task training program—combining physical exercises like walking with mental tasks like counting—can improve both motor and cognitive function in 16 boys aged 6–12 with Duchenne muscular dystrophy. Participants will be randomly assigned to either st…
Sponsor: Lokman Hekim University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New program aims to ease burden on families of kids with rare diseases
Symptom relief By invitation onlyThis study tests a program called FACE-Rare, designed to support family caregivers of children with rare, life-limiting diseases. The program includes three sessions to help families prepare for future medical decisions and improve their quality of life. Researchers will compare …
Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
No more tears at the dentist? new study tests fun videos and acupressure for Kids' tooth pulls
Symptom relief By invitation onlyThis study looks at two simple ways to help children feel less anxious and in less pain when getting a tooth pulled. One method uses a fun video to distract them, and the other uses gentle pressure on a specific point on the hand. The study will include 69 healthy children aged 5…
Sponsor: Mansoura University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Dance class may ease Parkinson's 'OFF-Time' and boost brain power
Symptom relief OngoingThis study tests whether partnered dance aerobic exercise can reduce 'OFF-time' (when Parkinson's medication stops working well) and improve thinking skills. Researchers will enroll 82 people with Parkinson's who experience OFF-time. Participants will take dance classes twice a w…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Tai chi tailored for Parkinson's shows promise in small trial
Symptom relief OngoingThis pilot study tests whether a Parkinson's-specific Tai Chi program can improve movement and non-movement symptoms like balance, fatigue, and mood. Thirty adults with mild to moderate Parkinson's will either take Tai Chi classes plus usual care or just usual care for 12 weeks. …
Sponsor: King's College Hospital NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New clinic aims to break the cycle of useless tests for fatigue sufferers
Symptom relief OngoingThis study tests a new, team-based rehabilitation program for 125 working-age adults with persistent physical symptoms and chronic fatigue. The program includes doctors, therapists, and counselors who work together to help patients manage their symptoms and improve daily function…
Sponsor: Turku University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Meditation before surgery may ease pain and anxiety for kidney stone patients
Symptom relief By invitation onlyThis pilot study tests whether daily meditation can improve recovery for children and adults having surgery for kidney stones. Participants will be randomly assigned to either a meditation group or a control group. Those in the meditation group will practice a daily 20-minute gui…
Sponsor: Children's Hospital of Philadelphia • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Could a zapping headband tame OCD?
Symptom relief OngoingThis study tests whether a gentle electrical current applied to the scalp (tDCS) can reduce obsessive-compulsive disorder (OCD) symptoms in people who haven't gotten better with standard therapy. 43 adults with severe, long-lasting OCD will receive either real or fake stimulation…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Could a common asthma drug help newborns breathe easier?
Symptom relief OngoingThis phase 3 trial tests whether inhaled salbutamol, a drug used for asthma, can help newborns with transient tachypnoea (rapid breathing after birth). About 608 babies born between 32 and 42 weeks will receive either salbutamol or a placebo. The goal is to see if the drug reduce…
Phase 3 • Sponsor: Medical University of Warsaw • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Earbuds that zap nerves could ease healthcare worker burnout
Symptom relief OngoingThis study tests whether a device called transcutaneous auricular vagus nerve stimulation (TaVNS) can reduce anxiety and distress in healthcare workers. Participants wear special earbuds that send gentle vibrations to stimulate the vagus nerve. Researchers will also use brain sca…
Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 26, 2026 18:20 UTC
-
Scientists track eye disease progression over five years
Knowledge-focused OngoingThis study follows 110 people who previously took part in the AREDS or AREDS2 trials to see how age-related macular degeneration (AMD) and cataracts change over time. Participants get a yearly eye exam, including vision tests and eye photos, and may give a blood sample. The goal …
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
10-Year NF1 study aims to unlock secrets of rare genetic disorder
Knowledge-focused OngoingThis natural history study follows 259 children, adolescents, and adults with Neurofibromatosis Type 1 (NF1) for up to 10 years. Researchers will track tumor growth, monitor quality of life, and perform genetic testing to better understand how the disease changes over time. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New tools aim to speed up FSHD drug trials
Knowledge-focused OngoingThis study involves 324 adults with facioscapulohumeral muscular dystrophy (FSHD) across 14 international sites. Researchers are testing two new measurement tools—a functional test called FSHD-COM and a muscle-impedance device—to better track disease progression. The goal is to i…
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a new questionnaire capture life with hereditary amyloidosis?
Knowledge-focused CancelledResearchers in Argentina are developing and testing a self-administered questionnaire to measure how hereditary transthyretin amyloidosis affects patients' physical, emotional, and social quality of life. The study includes input from neurologists, a cardiologist, a psychologist,…
Sponsor: Hospital General de Niños Pedro de Elizalde • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
NIH launches major study to unravel mysteries of rare genetic diseases
Knowledge-focused By invitation onlyThis study aims to identify genetic, biochemical, and clinical factors linked to disease severity in people with Gaucher disease and other lysosomal storage disorders. Researchers will evaluate up to 1,000 participants, including patients, carriers, and healthy controls, to bette…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Eye disease progression under the microscope: 3-Year study launched
Knowledge-focused OngoingThis study follows 400 people with intermediate age-related macular degeneration (AMD) for about 3 years. Researchers watch how the disease advances to more severe stages and test if measuring the loss of light-sensing cells in the eye can be a useful way to track the disease. No…
Sponsor: Genentech, Inc. • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Researchers hunt for muscle clues in rare dystrophy
Knowledge-focused OngoingThis pilot study looks at biomarkers in the blood of people with fragile sarcolemmal muscular dystrophy, a condition that makes muscle membranes weak. Researchers will collect blood samples at rest and after exercise during four 5-day hospital stays. The goal is to better underst…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track families to uncover Cancer's hidden causes
Knowledge-focused OngoingThis study looks at people and families who have a high risk of cancer to learn what genes and environmental factors might increase that risk. Over 5,000 participants are followed over time with questionnaires, medical records, and optional genetic testing. No treatment is given,…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can wearable sensors and walking tests reliably track nerve damage?
Knowledge-focused OngoingResearchers are checking whether tests of muscle strength, walking, balance, and fine motor skills give consistent results in people with polyneuropathy. About 520 adults with various forms of nerve damage, plus healthy volunteers, take part. Participants complete physical tests,…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New study hopes to outsmart pancreatic cancer by gathering clues
Knowledge-focused OngoingThis study collects health information and test results from 317 people at high risk for pancreatic cancer, including those with cysts, genetic syndromes, or other risk factors. Researchers aim to build a database to find better ways to detect the disease early or prevent it. No …
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New study tracks rare disease SCA7 to uncover clues for future treatments
Knowledge-focused OngoingThis study follows 25 people with spinocerebellar ataxia type 7 (SCA7) for up to 5 years to learn how the disease changes vision, coordination, and thinking. Participants will have yearly eye exams, brain scans, and neurological tests. No treatment is given; the goal is to gather…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Thousands tracked after carpal tunnel surgery: does new device deliver?
Knowledge-focused OngoingThis study is tracking 2000 adults with carpal tunnel syndrome who are having surgery to release the nerve. The surgery uses a special device called UltraGuideCTR, which is guided by ultrasound. Researchers are collecting real-world data on symptoms and hand function for up to 24…
Sponsor: Sonex Health, Inc. • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Swedish survey asks: what shapes daily life with chiari malformation?
Knowledge-focused By invitation onlyResearchers at Karolinska Institutet are surveying adults in Sweden who have Chiari malformation type 1, a condition where part of the brain pushes into the spinal canal. The study asks how these patients rate their health-related quality of life compared with the general Swedish…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
University health survey aims to uncover hidden struggles of students and staff
Knowledge-focused OngoingThis study is a health check for students at Constructor University Bremen and employees at HAW-Hamburg. Researchers will use surveys and interviews to measure loneliness, anxiety, stress, and health habits. The goal is to understand what affects wellbeing and find ways to suppor…
Sponsor: Jacobs University Bremen gGmbH • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
New registry tracks SMA in chinese kids to unlock Real-World insights
Knowledge-focused OngoingThis study is a registry that collects information on up to 600 children in China with spinal muscular atrophy (SMA). It aims to describe how the disease progresses and how treatments are used in everyday medical practice. The study does not test a new drug but gathers data to be…
Sponsor: Biogen • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
100,000 volunteers join digital brain health study to catch dementia early
Knowledge-focused By invitation onlyThis observational study will enroll 100,000 people over age 45 to track early signs of Alzheimer's and Parkinson's using smartphone-based tests, genetic data, and brain scans. Researchers aim to develop better ways to identify who is at risk before symptoms worsen. Participants …
Sponsor: Greece 2021 Committee • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Braces breakthrough? study tests which wire moves teeth faster
Knowledge-focused By invitation onlyThis study compares stainless steel and titanium-molybdenum alloy wires for moving canine teeth in people with braces. Sixteen participants will have one type of wire on each side of their upper jaw to see which works better. The goal is to find out which wire moves teeth more ef…
Sponsor: Tanzila Rafique • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Blood test could spot hidden tumors in NF1 patients
Knowledge-focused By invitation onlyThis study aims to find blood-based biomarkers that signal the presence and size of plexiform neurofibromas in people with Neurofibromatosis type 1 (NF1). Researchers will collect blood samples and use whole-body MRI to compare biomarker levels in 200 participants with different …
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Massive study aims to unlock secrets of childhood nerve and muscle diseases
Knowledge-focused OngoingThis long-term study looks at children and adults with inherited nerve and muscle disorders that start early in life, like muscular dystrophy. Researchers will track symptoms over time and collect genetic samples from affected individuals, their family members, and healthy volunt…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Parkinson's drug may impact gum disease risk
Knowledge-focused OngoingThis study looks at whether the Parkinson's drug Levodopa-Benserazide affects gum health and inflammation. Researchers will measure gum health and saliva markers in 136 people, including Parkinson's patients with and without gum disease, and healthy controls. The goal is to under…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
New study aims to sharpen tools for tracking becker muscular dystrophy
Knowledge-focused OngoingThis 24-month observational study will follow 80 people with Becker muscular dystrophy (BMD) to better understand how the disease progresses. Researchers will measure muscle strength, walking speed, breathing, and heart function using standard tests. The goal is to identify which…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Florida launches brain disease biobank to fuel future discoveries
Knowledge-focused OngoingThis study is creating a statewide collection of blood samples and medical information from people with various brain blood vessel diseases, such as stroke and dementia. The goal is to build a resource that scientists can use in future research to better understand and potentiall…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
A Baby's fidgets may reveal brain health: study tests early warning signs
Knowledge-focused OngoingResearchers are studying the natural fidgety movements of infants to see if these movements can help predict cerebral palsy and other developmental issues. They will follow 350 babies, including healthy full-term infants and those at higher risk due to medical conditions, trackin…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can we predict who will have memory issues after brain surgery for Parkinson's?
Knowledge-focused OngoingThis study follows 30 people with Parkinson's disease who are scheduled to receive deep brain stimulation (DBS). Researchers will test whether brain scans, thinking tests, and other measures can predict who might experience cognitive decline after surgery. Participants complete t…
Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Could a spin class recharge the Parkinson's brain?
Knowledge-focused OngoingThis study asks whether exercise can improve how the brain produces and uses energy in people with Parkinson's disease. Researchers will scan participants' brains before and after a six-month program of supervised aerobic cycling, comparing them to a group doing stretching or yog…
Sponsor: Pacific Parkinson's Research Centre • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Watching the brain and body during OCD triggers: a window into the disorder
Knowledge-focused OngoingResearchers at Baylor College of Medicine are studying how brain activity and visible behaviors, like head movements, facial expressions, and voice tone, change during tasks that trigger OCD symptoms. Adults with OCD and healthy volunteers will complete tasks that provoke distres…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Massive Real-World study tracks roche eye drugs in 6,000 patients
Knowledge-focused OngoingThis study is collecting long-term, real-world data from about 6,000 adults being treated with Roche eye medications (Faricimab or the Port Delivery System with Ranibizumab) for conditions like wet age-related macular degeneration and diabetic macular edema. The goal is to unders…
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New eye imaging could reveal hidden clues to vision loss
Knowledge-focused By invitation onlyThis study explores whether combining three eye-imaging techniques can reveal how structural damage in the retina relates to vision loss in people with geographic atrophy, a form of age-related macular degeneration. Researchers will use OCT scans, ultra-high-resolution AOSLO imag…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists track rare eye disease to prepare for future treatments
Knowledge-focused OngoingThis study follows 68 people aged 12 and older who have ABCA4 gene mutations, which can cause vision loss from diseases like Stargardt disease. Over 10 years, researchers will collect blood and skin samples and perform detailed eye exams to understand how the disease progresses. …
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Smart sensors could revolutionize rett syndrome monitoring
Knowledge-focused OngoingThis study tests whether wearable biosensors can accurately track symptoms like heart rate, breathing, sleep, and movement in people with Rett syndrome. Up to 30 participants will use the devices at home for 9 weeks and also undergo one overnight sleep study in the clinic. The go…
Sponsor: Rett Syndrome Research Trust • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
VHL tumor growth study aims to predict which lesions need surgery
Knowledge-focused OngoingThis 5-year study follows 250 people with von Hippel-Lindau disease who have brain or spinal cord tumors. Researchers use regular MRI scans and blood tests to see how fast tumors grow and what factors like hormones might affect growth. The goal is to better understand which tumor…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Blood test could spot rare nerve tumors years earlier in NF1 patients
Knowledge-focused By invitation onlyThis study is testing whether a blood test (liquid biopsy) can detect a rare but serious nerve tumor called MPNST earlier than current methods in adults with Neurofibromatosis Type 1 (NF1). Researchers will compare the timing of tumor detection by the blood test versus standard i…
Sponsor: David Miller • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Massive Alzheimer's study aims to unlock secrets of memory loss
Knowledge-focused By invitation onlyThis study follows 1,500 volunteers with normal memory, mild cognitive impairment, or Alzheimer's over several years. Researchers use brain scans, memory tests, and blood samples to track how the disease progresses. The goal is to find better ways to diagnose and treat Alzheimer'…
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Sniffing out Parkinson's: new study uses nose, blood, and urine to catch disease early
Knowledge-focused OngoingThis study aims to find early markers of Parkinson's disease, multiple system atrophy, and Lewy body dementia by analyzing samples from the nose, blood, and urine. Researchers will compare results from 180 people with these conditions and healthy volunteers. The goal is to improv…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Scientists hunt for hidden signs of ALS and FTD in skin and tears
Knowledge-focused OngoingThis study aims to find biological markers (biosignatures) in people with ALS and FTD to make diagnosis more precise. Researchers will analyze samples like spinal fluid, skin, and tears from 230 participants using advanced techniques. The goal is to create a 'disease fingerprint'…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Can your smartwatch predict a stress breakdown?
Knowledge-focused By invitation onlyThis study will use wearable devices like heart rate monitors and sleep trackers to see how financial stress and news affect your body. Researchers will follow 2,500 adults remotely, collecting data on heart rate, sleep, and stress levels. The goal is to create AI tools that can …
Sponsor: Truway Health, Inc. • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Counting the uncounted: a nationwide look at two rare epilepsies
Knowledge-focused CancelledThis observational study aims to measure how many people in Portugal have Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS), two rare and severe forms of epilepsy. Researchers will review existing medical records from about three public hospitals to estimate the percentage of…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Scientists track rare eye disease to uncover clues for future treatments
Knowledge-focused OngoingThis study follows 46 people with gyrate atrophy, a rare genetic condition that causes vision loss, over 4 years. Researchers measure ornithine levels in the blood and track changes in the retina using eye scans and photos. The goal is to learn how the disease progresses under st…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Can MRI scans reveal the hidden pattern of muscle damage in a rare muscular dystrophy?
Knowledge-focused OngoingThis study aims to describe the pattern of muscle involvement in people with limb girdle muscular dystrophy caused by mutations in the anoctamin 5 gene. Researchers will collect and analyze MRI scans from 200 participants to see which muscles are affected and how much fat replace…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Could a brain disease change behavior years before diagnosis?
Knowledge-focused OngoingThis study investigates whether people with neurodegenerative diseases—like Alzheimer's, Parkinson's, or ALS—show changes in behavior, social circumstances, or health before and after their diagnosis. Researchers will compare the records of over 61,000 patients with those of matc…
Sponsor: Kuopio University Hospital • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Major study aims to unlock mysteries of Early-Onset Alzheimer's
Knowledge-focused OngoingThis study follows 850 people aged 40-64 with early-onset cognitive impairment to understand how Alzheimer's disease progresses. Participants undergo cognitive tests, brain scans, and genetic analysis, but no experimental treatment is given. The goal is to gather data that could …
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Sleep disorder may hold key to predicting Parkinson's before symptoms start
Knowledge-focused OngoingThis study investigates whether a combination of brain MRI scans, sleep recordings, and cognitive tests can track early brain changes in people with idiopathic REM sleep behavior disorder (iRBD), a condition that often precedes Parkinson's disease. Researchers will follow 50 peop…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Could a common virus trigger mental illness? massive study investigates
Knowledge-focused OngoingThis study uses health records from about 100,000 people in Israel to see if past viral infections (like Epstein-Barr, COVID-19, or herpes) increase the risk of developing mental illnesses such as depression, anxiety, bipolar disorder, or schizophrenia. It also looks at whether i…
Sponsor: Shalvata Mental Health Center • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Eye disease study aims to pave way for future treatments
Knowledge-focused OngoingThis study follows 127 people with a genetic eye condition called USH2A-related retinal degeneration, which can cause vision loss and hearing problems. Researchers measure changes in vision, retinal sensitivity, and mobility over several years. The goal is to understand how the d…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can mapping a rare Gene's effects pave the way to targeted epilepsy therapies?
Knowledge-focused OngoingThis study follows children aged 6 to 21 who have a CNKSR2 gene mutation, which can cause epilepsy, language difficulties, and intellectual disability. Researchers will use brain scans, EEGs, and developmental tests to track how the condition changes over time. The goal is to cre…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Brain function in Friedreich's ataxia: new clues from genetic testing
Knowledge-focused OngoingThis study looks at how Friedreich's ataxia, a genetic nerve disease, affects thinking skills like memory and problem-solving. Researchers will compare cognitive test results between people with the condition and healthy volunteers, and see if these results relate to the number o…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Brain scans aim to unlock mysteries of muscle disease
Knowledge-focused By invitation onlyThis study looks at how myotonic dystrophy types 1 and 2 affect the brain. About 100 adults aged 30-65 will have MRI scans, thinking and movement tests, and blood draws. Some will also have a spinal tap. The goal is to find brain changes that could be used as markers in future tr…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Why do people grind their teeth at night? new study seeks answers
Knowledge-focused By invitation onlyThis study looks at 50 adults with sleep bruxism (teeth grinding during sleep) to understand how it affects sleep, pain, anxiety, and overall health. Researchers will use sleep tests, blood samples, and questionnaires to find links between bruxism and other conditions. The goal i…
Sponsor: Wroclaw Medical University • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Scientists hunt for early warning signs of Parkinson's
Knowledge-focused OngoingThis observational study follows people with early Parkinson's disease, those at genetic risk, and healthy volunteers over time. Researchers collect clinical exams, brain scans, and biological samples (blood, spinal fluid, skin, stool) to identify markers that predict how the dis…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Researchers track rare nerve disease to unlock future treatments
Knowledge-focused OngoingThis study follows 20 people with a rare nerve disease called CMT4J for up to 2 years. Researchers will track symptoms and health changes to better understand how the disease progresses. The goal is to find better ways to measure the disease, which could help design future treatm…
Sponsor: Elpida Therapeutics SPC • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Eye surgery silicone may change cornea cells, study finds
Knowledge-focused OngoingThis study looks at how silicone oil, used to repair detached retinas, affects the cells on the inner surface of the cornea. Researchers will measure cell density and shape changes in 40 patients at 1 and 3 months after surgery. They also want to see if any changes go away after …
Sponsor: Minia University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Withdrawn study sought better way to time eye injections
Knowledge-focused CancelledThis study aimed to see if how well a person can fix their gaze relates to signs of active disease on eye scans in patients with age-related macular degeneration (ARMD) treated with antiVEGF injections. Researchers planned to follow patients for two years, measuring fixation qual…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Cushing's disease study in western france withdrawn before starting
Knowledge-focused CancelledThis study was designed to look back at the health of people with Cushing's disease in Western France between 1990 and 2015. The goal was to find out how many patients went into remission and how many had their disease come back after their first surgery. However, the study was w…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Alzheimer's gut study pulled before it even started
Knowledge-focused CancelledThis study aimed to see if Alzheimer's disease affects the nerves in the gut, similar to what happens in Parkinson's disease. Researchers planned to take extra colon biopsies during routine colonoscopies from people with Alzheimer's, Parkinson's, and healthy individuals to compar…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Can a One-Page guide spark better End-of-Life talks for dementia patients?
Knowledge-focused OngoingThis study tests a short guide called the 'Jumpstart Guide' to help doctors have better conversations with dementia patients and their families about healthcare goals. Over 1,800 patients and their caregivers are taking part. Researchers will compare whether those whose doctors u…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Massive 30-Year Women's health study reveals hidden disease links
Knowledge-focused OngoingThis long-running study follows nearly 100,000 French women, mostly teachers, since 1990 to understand what factors influence their risk of cancer, heart disease, diabetes, and other major illnesses. Participants fill out questionnaires every few years about their lifestyle, medi…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scientists track Long-Term safety of experimental AMD therapy
Knowledge-focused By invitation onlyThis study follows people with advanced dry age-related macular degeneration who previously received a one-time injection of the experimental treatment VOY-101. Researchers are monitoring participants over the long term to check for any side effects related to the treatment. The …
Sponsor: Perceive Biotherapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists hunt for clues to diagnose Parkinson's earlier
Knowledge-focused OngoingThis study aims to identify biomarkers—biological clues in the body—that can help distinguish between Parkinson's disease and similar conditions like progressive supranuclear palsy and multiple system atrophy. Researchers will follow people with early-stage parkinsonism and healt…
Sponsor: Non-profit organization for scientific research in Parkinson's disease and related disorders • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Forgotten side effect: new study tracks leg swelling in men with prostate cancer
Knowledge-focused OngoingThis study follows 214 men treated for prostate cancer to see how many develop lower limb lymphedema (leg swelling) and who is most at risk. Participants attend check-ups every three months for 18 months. The goal is to better understand this side effect and its impact on quality…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists hunt for clues in genes and body fluids to unlock ALS mysteries
Knowledge-focused OngoingThis study is observing 217 people with ALS and related conditions like frontotemporal dementia and hereditary spastic paraplegia. Researchers aim to connect each person's genetic makeup with their symptoms and find biological markers in blood and spinal fluid. No new treatments …
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
AI and wearables join forces to uncover Dementia's hidden clues
Knowledge-focused OngoingThis study investigates how genetic, lifestyle, and biological factors relate to memory and thinking problems in people over 60 with Alzheimer's disease, Parkinson's disease, or mild cognitive impairment. Researchers will use brain scans, spinal fluid and blood tests, and data fr…
Sponsor: IRCCS San Raffaele Roma • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Paving the way: new study aims to sharpen tools for LGMD R1 trials
Knowledge-focused OngoingThis 24-month observational study follows 100 people aged 12–50 with Limb Girdle Muscular Dystrophy type R1 (LGMD R1). Researchers will test whether a motor function scale called NSAD and muscle fat measurements from MRI can reliably track disease progression. The goal is to vali…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Brain leak clue to chronic fatigue and long COVID brain fog?
Knowledge-focused By invitation onlyThis Johns Hopkins study looks at whether a leaky blood-brain barrier and immune changes contribute to cognitive problems in people with ME/CFS (chronic fatigue syndrome), both those who got sick before the pandemic and those who developed it after COVID-19. Researchers will use …
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Ground-Level vision test could help retinitis pigmentosa patients walk better
Knowledge-focused CancelledThis study was designed to see if a new method of measuring the visual field—by projecting vision zones on the ground—helps people with retinitis pigmentosa understand their remaining sight and improve their walking rehabilitation. The trial was withdrawn before enrolling any par…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Radioactive tracer reveals tau tangles in Alzheimer's brains
Knowledge-focused By invitation onlyThis study tests a new radioactive compound called F 18 T807 that lights up tau tangles in the brain during a PET scan. Researchers want to see if the amount of tau relates to memory and thinking problems in people with a rare, inherited form of Alzheimer's disease. About 130 adu…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New brain scan tracks Alzheimer's protein in real time
Knowledge-focused By invitation onlyThis study uses a radioactive tracer called [18F]MK-6240 to take detailed pictures of tau protein clumps in the brain, a hallmark of Alzheimer's disease. Researchers will scan 200 people from families with a rare genetic form of Alzheimer's to see how tau buildup changes over tim…
Sponsor: Tammie L. S. Benzinger, MD, PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New study tracks how DM1 affects chinese patients over time
Knowledge-focused By invitation onlyThis study follows 1000 Chinese patients with myotonic dystrophy type 1 (DM1) to understand how the disease affects multiple body systems and leads to disability. Researchers will collect health data and blood samples every 3 to 6 months for several years. The goal is to identify…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Eggs on the menu: could a daily dozen slow vision loss?
Knowledge-focused OngoingThis pilot study tests whether older adults with intermediate age-related macular degeneration (AMD) can eat 2 or 4 whole eggs daily for 5 months. The main goal is to see if people can stick with the diet, not to prove eggs improve vision. Researchers will also measure changes in…
Early phase 1 • Sponsor: Kathryn Starr • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Brain monitor may guide safer blood pressure during surgery
Knowledge-focused OngoingThis study looks at whether low blood pressure during major noncardiac surgery harms organs like the heart and kidneys. Researchers are using a non-invasive brain monitor to see if a personalized blood pressure target can be set. 650 patients at cardiovascular risk are being obse…
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Blood pressure clues may predict early death after heart attack
Knowledge-focused OngoingThis study examines whether a low pulse pressure (the difference between top and bottom blood pressure numbers) in the first hours after a cardiac arrest is linked to early death. Researchers will analyze data from 3500 patients who had a cardiac arrest outside the hospital and a…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Brain scans reveal diabetes link to cognitive decline in rare disease
Knowledge-focused OngoingThis study looks at whether diabetes or blood sugar problems can worsen thinking and memory issues in people with myotonic dystrophy type 1. Researchers will use MRI brain scans and thinking tests over 4 years to track changes. The goal is to understand why some patients have mor…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can tracking rigid thoughts improve addiction treatment?
Knowledge-focused By invitation onlyThis study observes 35 people in residential treatment for substance use disorders to measure behavioral rigidity—the tendency to get stuck in inflexible thinking patterns. Participants complete weekly questionnaires and have their therapy sessions analyzed for language patterns.…
Sponsor: Lauro Gutiérrez Castro • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Sleep disorder study could pave way for Parkinson's prevention
Knowledge-focused By invitation onlyThis study enrolls 500 adults with a sleep condition called REM sleep behavior disorder (RBD), which often leads to Parkinson's disease or related brain disorders. Researchers will track symptoms like thinking, movement, and smell to develop a rating scale. The goal is to prepare…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Scientists map hidden tumor diversity in rare kidney cancer
Knowledge-focused OngoingThis study aims to understand why kidney tumors in people with VHL syndrome can be different from each other. Researchers will use advanced imaging, multiple biopsies, and lab-grown tumor models to map these differences. The goal is to learn more about the disease, not to test a …
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
VHL patients share their struggles in new quality-of-life survey
Knowledge-focused OngoingThis study asks 200 adults with von Hippel-Lindau syndrome to fill out an anonymous online questionnaire about their quality of life, psychological well-being, and difficulties accessing care. No treatment or medical tests are involved — the goal is simply to learn what patients …
Sponsor: IRCCS Ospedale San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can a VR game make rehab fun for kids with duchenne?
Knowledge-focused By invitation onlyThis study is testing a virtual reality game designed specifically for people with Duchenne muscular dystrophy (DMD). Six participants aged 7 and older will play the game once using a VR headset and hand tracking. Researchers will measure how easy and enjoyable the game is, and w…
Sponsor: Istanbul University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
French-Language scale for rare nerve disease put to the test
Knowledge-focused OngoingThis study checks whether a French version of a scale called PLSFRS works well for people with primary lateral sclerosis (PLS), a rare nerve disease. Researchers will ask 80 patients to fill out the questionnaire during routine check-ups every 3 to 6 months. The goal is to see if…
Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Med student stress may be tied to wrist pain, new study suggests
Knowledge-focused By invitation onlyThis study looks at whether anxiety and depression are connected to carpal tunnel syndrome in medical students. Researchers will measure the median nerve in the wrist and check students' anxiety and depression levels using questionnaires. The goal is to see if there is a link bet…
Sponsor: University of Ioannina • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Why do some blind people see things that Aren't there? new study aims to find out
Knowledge-focused By invitation onlyThis study looks at how common Charles Bonnet Syndrome (CBS) is in people with vision loss from conditions like macular degeneration or glaucoma. CBS causes complex visual hallucinations without mental illness. Researchers will survey 640 participants to measure how often it happ…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Eye fluid test could spot dry AMD changes early
Knowledge-focused OngoingThis study is testing whether taking a tiny sample of fluid from the front of the eye is safe for people with dry age-related macular degeneration (AMD). Researchers will analyze proteins in the fluid to see if they change over time. The study includes 50 adults aged 50 to 89, so…
Sponsor: ClinOmicsAI • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New model aims to speed up rare disease diagnosis
Knowledge-focused OngoingThis study is testing a new way to care for people with rare diseases. It will use advanced genetic testing and a team of specialists to help diagnose patients faster and coordinate their care better. The study involves 136 participants with certain rare diseases and aims to redu…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Unsteady gait in seniors may be a treatable brain disorder, new study suggests
Knowledge-focused By invitation onlyThis study follows 450 older adults to understand why many develop a slow, unsteady walk. Researchers think it may be linked to a treatable brain condition called Normal Pressure Hydrocephalus. They will use brain scans and track health outcomes over six years to find better ways…
Sponsor: Umeå University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Brain implant learns to read OCD signals in real time
Knowledge-focused OngoingThis study tests an adaptive deep brain stimulation (aDBS) system in just 3 people with severe, treatment-resistant OCD. The device is implanted in the brain and chest, and it aims to detect brain signals linked to OCD distress and adjust stimulation automatically. The main goal …
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Your income and social life may predict brain health, study finds
Knowledge-focused By invitation onlyThis study looks at how things like social support, income, and health habits are linked to mental health and brain diseases such as depression, Alzheimer's, and Parkinson's. Researchers will collect surveys, blood samples, and optional brain scans from over 1,300 adults in Europ…
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Study on video calls for Alzheimer's caregivers pulled before starting
Knowledge-focused CancelledThis study was designed to test whether scheduled video calls with a nurse could help family members who make medical decisions for hospitalized older adults with Alzheimer's or similar cognitive issues. The goal was to improve communication and reduce anxiety and depression. How…
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New tool aims to protect rights of those with memory loss
Knowledge-focused OngoingThis study is creating a simple test to check if people with Alzheimer's or similar conditions can understand and agree to medical decisions. Researchers will work with 100-150 participants to compare the new test with existing methods and look at brain scans and blood markers. T…
Sponsor: Ludwig-Maximilians - University of Munich • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Global brain surgery matchmaker aims to help kids with rare movement disorders
Knowledge-focused By invitation onlyThis study is building an online platform called DBS MatchMaker to connect doctors around the world who treat rare movement disorders with deep brain stimulation (DBS). The goal is to help doctors share knowledge and find the best ways to treat patients. Up to 500 people of all a…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New mHealth program aims to lower depression and stress in black pregnant women
Knowledge-focused OngoingThis study tests whether a culturally tailored mobile health program can improve mental health and pregnancy outcomes in Black pregnant women. Half of the 150 participants will receive the program, which builds communication and self-advocacy skills and provides support. The goal…
Phase 2/3 • Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New study observes patients getting nasal stem cell therapy for brain conditions
Knowledge-focused By invitation onlyThis observational study follows 36 people with neurologic conditions like traumatic brain injury, cerebral palsy, multiple sclerosis, or Alzheimer's who are already receiving intranasal MuSE stem cell or exosome therapy as part of their routine care. Researchers track safety and…
Sponsor: Healing Hope International • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Swimming study tests gentle exercise for chronic fatigue sufferers
Knowledge-focused PausedThis pilot study looks at whether light, self-paced swimming is a tolerable activity for people with ME/CFS and related conditions like Long COVID and fibromyalgia. Participants will swim for 15-30 minutes at their own pace and track symptoms and heart rate variability using an a…
Sponsor: Simon Fraser University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Sleep apnea treatment may help blood pressure, especially in the very sleepy
Knowledge-focused OngoingThis study looks at whether treating obstructive sleep apnea (OSA) with a breathing device (CPAP) lowers blood pressure more in people who are very sleepy compared to those who are not. Researchers will analyze data from about 10,000 adults with OSA from previous studies. The goa…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New study aims to unravel the mystery of fatigue in aging and Parkinson's
Knowledge-focused OngoingThis study looks at how tiredness affects daily life and muscle function in older adults (65+) and people with Parkinson's disease. Researchers will use questionnaires and simple exercises like handgrip and leg movements to measure fatigue. The goal is to better understand fatigu…
Sponsor: University of Applied Sciences and Arts of Southern Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Walking study for Parkinson's and stroke patients withdrawn before starting
Knowledge-focused CancelledThis study was designed to test a wearable sensor system that tracks how people walk on different surfaces like grass, pavement, and stairs. It aimed to include healthy volunteers and people with conditions such as Parkinson's disease, dementia, stroke, multiple sclerosis, or low…
Sponsor: University of Leeds • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Nuts vs. disease: Million-Person study seeks answers
Knowledge-focused OngoingThis study looks at data from 1 million adults worldwide to see if eating nuts is linked to a lower risk of diseases like diabetes, heart disease, cancer, and dementia. Researchers will combine information from many past studies to get clearer answers. The goal is to understand i…
Sponsor: Institut Investigacio Sanitaria Pere Virgili • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Eye pressure clue could sharpen vision after retinal surgery
Knowledge-focused OngoingThis study looks at whether having low eye pressure before surgery changes how well doctors can predict your final glasses prescription after a combined cataract and retinal detachment repair. Researchers will compare two groups of people: those with low eye pressure and those wi…
Sponsor: Kazakh Eye Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New national registry aims to improve care for rare genetic polyposis syndromes
Knowledge-focused OngoingThis study is a national registry collecting data from 1500 people with familial adenomatous polyposis (FAP) and related conditions across 28 Italian centers. It aims to better understand how these diseases progress, how they are currently managed, and what factors influence outc…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Global data pooling aims to unlock secrets of rare muscle disease
Knowledge-focused OngoingThis study brings together patient registries from 10 countries to analyze data from 700 people with spinal and bulbar muscular atrophy (SBMA). Researchers will look at changes in muscle function, walking ability, and age of symptom onset. The goal is to better understand how the…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Massive brain study aims to unlock secrets of dementia
Knowledge-focused OngoingThis long-term study uses yearly brain scans, genetic tests, and thinking/memory assessments to track changes in nearly 1,800 people with various dementias (like Alzheimer's and vascular dementia) and over 140 healthy older adults. The goal is to better diagnose, monitor, and eve…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Can a simple blood test unlock secrets of Alzheimer's and depression?
Knowledge-focused By invitation onlyThis study is analyzing blood samples from 1,799 people with Alzheimer's, dementia, depression, bipolar disorder, schizophrenia, or Parkinson's disease. Researchers want to see if certain substances in the blood can help doctors diagnose and manage these conditions more accuratel…
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Skin test could reveal Parkinson's progression
Knowledge-focused OngoingThis study uses a small skin sample to measure levels of a protein linked to Parkinson's disease and REM sleep behavior disorder. Researchers will follow 100 participants for 18 months to see if changes in the protein match disease progression. The goal is to develop a simple bio…
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Scientists dig into the Body's wiring after COVID: what causes POTS?
Knowledge-focused OngoingThis study looks at what happens in the body to cause POTS and dysautonomia after viral infections, including COVID-19. About 100 women will give a blood sample and share medical records. Researchers will study immune system markers to find clues that could lead to better diagnos…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Scientists hunt for hidden genes behind aortic aneurysms
Knowledge-focused OngoingThis study aims to uncover the genetic roots of aortic aneurysms and valve disease by analyzing tissue and blood samples from 3,000 participants. Researchers will look for new disease-causing genes and factors that affect disease severity. The goal is to build a biorepository to …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Researchers track Long-Term effects of duchenne gene therapy
Knowledge-focused By invitation onlyThis study follows about 400 people with Duchenne muscular dystrophy who have already received the gene therapy SRP-9001 in an earlier study. The goal is to monitor their safety and muscle function over time. No new treatment is given in this study.
Phase 3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Scientists map rare blindness to speed future cures
Knowledge-focused OngoingThis study follows 44 people with a rare genetic form of Usher syndrome caused by PCDH15 mutations. Over 48 months, researchers measure how their vision changes using eye exams and imaging. The goal is to identify the best ways to track disease progression, which will help design…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Brain scans may predict who benefits from moyamoya surgery
Knowledge-focused By invitation onlyThis study uses advanced MRI scans to measure blood flow in the brains of 100 adults with moyamoya disease, a condition that narrows major brain arteries and raises stroke risk. Participants will have scans and cognitive tests before and after their clinically needed surgery. The…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New study tracks muscle decline in rare muscular dystrophy
Knowledge-focused OngoingThis study follows 25 people with limb-girdle muscular dystrophy type 2A (LGMD2A), a rare genetic disease that causes progressive muscle weakness. Researchers will measure how muscle strength changes over time and how it affects quality of life. The goal is to better understand t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New study aims to predict sudden death in severe epilepsy
Knowledge-focused OngoingThis study looks at how repeated seizures affect breathing and heart function in people with Dravet syndrome, a severe form of epilepsy. Researchers will monitor 92 children and adults for 24-48 hours using video, brain wave, heart, and breathing recordings. The goal is to find c…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Join the brain health registry and help fight Alzheimer's from home
Knowledge-focused By invitation onlyThe Brain Health Registry is an online project that collects information about memory, mood, sleep, diet, and exercise from adults over 18. Participants also take simple cognitive tests online. The goal is to build a large database to speed up research into brain diseases like Al…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Trauma ICU survivors: new study tracks hidden brain decline
Knowledge-focused OngoingThis study follows 432 adults who were in the ICU after a traumatic injury or burn. Researchers want to see if and why patients develop long-term problems with memory, thinking, and daily function. By tracking cognitive skills and inflammation over time, they hope to uncover link…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Heart check: do Nerve-Targeting drugs also shield the heart in rare amyloidosis?
Knowledge-focused OngoingThis study follows 20 adults with hereditary transthyretin amyloidosis (ATTRv) who have both nerve and heart involvement. They are treated with patisiran or vutrisiran for two years. Researchers use MRI scans and questionnaires to see how the drugs affect heart structure and func…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New pathway aims to cut wait times for carpal tunnel patients
Knowledge-focused By invitation onlyThis study looks at whether a new care pathway can shorten wait times for people with carpal tunnel syndrome. Researchers will compare wait times before and after the pathway is put in place. About 200 adults will take part and fill out a short satisfaction survey.
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Parkinson's study watches symptoms without new drugs
Knowledge-focused By invitation onlyThis study follows 96 people with moderate Parkinson's disease for up to 24 months. Participants take their usual medications, and doctors may adjust them as needed. Researchers will track motor symptoms using standard rating scales to better understand how the disease progresses…
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Can combining mental and physical tasks boost brain rehab?
Knowledge-focused OngoingThis study is testing whether rehabilitation that combines physical and mental exercises (called dual-task training) can help people with stroke, multiple sclerosis, Parkinson's disease, or long COVID. Researchers will design and try out different dual-task strategies in small gr…
Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New study aims to speed up FSHD drug development
Knowledge-focused OngoingThis study is working to create better tools for measuring muscle function in people with facioscapulohumeral muscular dystrophy (FSHD). Researchers will follow 100 adults with FSHD for up to 24 months, testing new ways to track disease progression. The goal is to make future cli…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Heart scans aim to uncover hidden damage in duchenne patients
Knowledge-focused CancelledThis study was designed to track heart muscle changes in people with Duchenne muscular dystrophy using two cardiac MRIs taken two years apart, along with blood tests for heart failure markers. It planned to enroll participants aged 6 and older with a confirmed genetic diagnosis. …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Mayo clinic launches major brain disease tracking study
Knowledge-focused By invitation onlyThis study aims to learn more about diseases that affect the brain, such as Parkinson's disease and different types of dementia. Researchers will follow 500 adults with symptoms of these conditions over time, using brain scans and genetic tests to see how the diseases progress. T…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Wearable sensors track tiny movements in SMA babies on Cutting-Edge therapies
Knowledge-focused OngoingThis study follows 35 infants with spinal muscular atrophy (SMA) who are receiving gene therapy or other advanced treatments. Researchers use small wearable motion sensors to measure how well the babies move their arms and legs over two years. The goal is to create a more precise…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:15 UTC
-
Can yearly MRIs catch second cancers in retinoblastoma survivors?
Knowledge-focused OngoingThis study looks at whether yearly MRI scans can find new head and neck or brain cancers early in people who had hereditary retinoblastoma and were treated with radiation. Researchers will follow 88 participants for 10 years to see if early detection leads to better surgery outco…
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:56 UTC
-
Real-World data sought on DMD Exon-Skipping drugs
Knowledge-focused By invitation onlyThis observational study will follow 300 people with Duchenne muscular dystrophy who are already taking exon-skipping therapies (eteplirsen, golodirsen, or casimersen) as part of their routine care. Researchers will collect data on movement, lung function, and heart function over…
Sponsor: Sarepta Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:35 UTC
-
Simple blood test may predict Parkinson's progression
Knowledge-focused By invitation onlyThis study looks at whether prolactin (a hormone) and certain inflammation markers in the blood are linked to how severe Parkinson's disease is. Researchers will measure these in 300 people with Parkinson's and compare them to standard disease severity scores. The goal is to find…
Sponsor: Çanakkale Onsekiz Mart University • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:12 UTC
-
Can a Wrist-Worn tracker improve Parkinson's care?
Knowledge-focused OngoingThis study tests whether a wrist-worn movement recorder, called the Personal KinetiGraph (PKG), helps doctors make better treatment decisions for people with Parkinson's disease. About 231 participants will be split into two groups: one where the doctor sees the PKG data during t…
Sponsor: Global Kinetics Corporation • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:44 UTC